
<html lang="en"     class="pb-page"  data-request-id="7ee10ac4-5d47-49c6-b8b6-4b1d48518350"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.5b00098;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2015.58.issue-6;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery and Optimization of a Novel Series of Dyrk1B Kinase Inhibitors To Explore a MEK Resistance Hypothesis" /></meta><meta name="dc.Creator" content="Jason G.  Kettle" /></meta><meta name="dc.Creator" content="Peter  Ballard" /></meta><meta name="dc.Creator" content="Catherine  Bardelle" /></meta><meta name="dc.Creator" content="Mark  Cockerill" /></meta><meta name="dc.Creator" content="Nicola  Colclough" /></meta><meta name="dc.Creator" content="Susan E.  Critchlow" /></meta><meta name="dc.Creator" content="Judit  Debreczeni" /></meta><meta name="dc.Creator" content="Gary  Fairley" /></meta><meta name="dc.Creator" content="Shaun  Fillery" /></meta><meta name="dc.Creator" content="Mark A.  Graham" /></meta><meta name="dc.Creator" content="Louise  Goodwin" /></meta><meta name="dc.Creator" content="Sylvie  Guichard" /></meta><meta name="dc.Creator" content="Kevin  Hudson" /></meta><meta name="dc.Creator" content="Richard A.  Ward" /></meta><meta name="dc.Creator" content="David  Whittaker" /></meta><meta name="dc.Description" content="Potent and selective inhibitors of Dyrk1B kinase were developed to explore the hypothesis, based on siRNA studies, that Dyrk1B may be a resistance mechanism in cells undergoing a stress response." /></meta><meta name="Description" content="Potent and selective inhibitors of Dyrk1B kinase were developed to explore the hypothesis, based on siRNA studies, that Dyrk1B may be a resistance mechanism in cells undergoing a stress response." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 12, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00098" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00098" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00098" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00098" /></link>
        
    
    

<title>Discovery and Optimization of a Novel Series of Dyrk1B Kinase Inhibitors To Explore a MEK Resistance Hypothesis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00098" /></meta><meta property="og:title" content="Discovery and Optimization of a Novel Series of Dyrk1B Kinase Inhibitors To Explore a MEK Resistance Hypothesis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0013.jpeg" /></meta><meta property="og:description" content="Potent and selective inhibitors of Dyrk1B kinase were developed to explore the hypothesis, based on siRNA studies, that Dyrk1B may be a resistance mechanism in cells undergoing a stress response." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00098"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00098">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00098&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00098&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00098&amp;href=/doi/10.1021/acs.jmedchem.5b00098" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2834-2844</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00043" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b00253" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Optimization of a Novel Series of Dyrk1B Kinase Inhibitors To Explore a MEK Resistance Hypothesis</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jason+G.++Kettle">Jason G. Kettle</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Ballard">Peter Ballard</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Catherine++Bardelle">Catherine Bardelle</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Cockerill">Mark Cockerill</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicola++Colclough">Nicola Colclough</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+E.++Critchlow">Susan E. Critchlow</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Judit++Debreczeni">Judit Debreczeni</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary++Fairley">Gary Fairley</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shaun++Fillery">Shaun Fillery</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+A.++Graham">Mark A. Graham</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Louise++Goodwin">Louise Goodwin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sylvie++Guichard">Sylvie Guichard</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Hudson">Kevin Hudson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard+A.++Ward">Richard A. Ward</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Whittaker">David Whittaker</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Oncology iMed, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom</span></div><div class="corresp-info"><strong>*</strong>Tel.: +441625 517920. E-mail: <a href="/cdn-cgi/l/email-protection#aac0cbd9c5c484c1cfdedec6cfeacbd9ded8cbd0cfc4cfc9cb84c9c5c7"><span class="__cf_email__" data-cfemail="c3a9a2b0acadeda8a6b7b7afa683a2b0b7b1a2b9a6ada6a0a2eda0acae">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00098&amp;href=/doi/10.1021%2Facs.jmedchem.5b00098" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2834–2844</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 4, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 January 2015</li><li><span class="item_label"><b>Published</b> online</span>12 March 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 March 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00098" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00098</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2834%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJason%2BG.%2BKettle%252C%2BPeter%2BBallard%252C%2BCatherine%2BBardelle%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D6%26contentID%3Dacs.jmedchem.5b00098%26title%3DDiscovery%2Band%2BOptimization%2Bof%2Ba%2BNovel%2BSeries%2Bof%2BDyrk1B%2BKinase%2BInhibitors%2BTo%2BExplore%2Ba%2BMEK%2BResistance%2BHypothesis%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2844%26publicationDate%3DMarch%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00098"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3356</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00098" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Optimization of a Novel Series of Dyrk1B Kinase Inhibitors To Explore a MEK Resistance Hypothesis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;G. Kettle&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Ballard&quot;},{&quot;first_name&quot;:&quot;Catherine&quot;,&quot;last_name&quot;:&quot;Bardelle&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Cockerill&quot;},{&quot;first_name&quot;:&quot;Nicola&quot;,&quot;last_name&quot;:&quot;Colclough&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;E. Critchlow&quot;},{&quot;first_name&quot;:&quot;Judit&quot;,&quot;last_name&quot;:&quot;Debreczeni&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;Fairley&quot;},{&quot;first_name&quot;:&quot;Shaun&quot;,&quot;last_name&quot;:&quot;Fillery&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;A. Graham&quot;},{&quot;first_name&quot;:&quot;Louise&quot;,&quot;last_name&quot;:&quot;Goodwin&quot;},{&quot;first_name&quot;:&quot;Sylvie&quot;,&quot;last_name&quot;:&quot;Guichard&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Hudson&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;A. Ward&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Whittaker&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;2834-2844&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00098&quot;},&quot;abstract&quot;:&quot;Potent and selective inhibitors of Dyrk1B kinase were developed to explore the hypothesis, based on siRNA studies, that Dyrk1B may be a resistance mechanism in cells undergoing a stress response.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00098&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00098" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00098&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00098" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00098&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00098" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00098&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00098&amp;href=/doi/10.1021/acs.jmedchem.5b00098" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00098" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00098" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00098%26sid%3Dliteratum%253Aachs%26pmid%3D25738750%26genre%3Darticle%26aulast%3DKettle%26date%3D2015%26atitle%3DDiscovery%2Band%2BOptimization%2Bof%2Ba%2BNovel%2BSeries%2Bof%2BDyrk1B%2BKinase%2BInhibitors%2BTo%2BExplore%2Ba%2BMEK%2BResistance%2BHypothesis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D6%26spage%3D2834%26epage%3D2844%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jmcmar.2015.58.issue-6/20150326/jmcmar.2015.58.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Potent and selective inhibitors of Dyrk1B kinase were developed to explore the hypothesis, based on siRNA studies, that Dyrk1B may be a resistance mechanism in cells undergoing a stress response.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82714" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82714" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Dyrk1B (also known as Mirk or Minibrain-related kinase) is a dual-specificity serine–threonine kinase that has been shown to mediate survival and differentiation in skeletal muscle, in which it is expressed at higher levels relative to that in other normal tissues.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> It is a member of the Minibrain/Dyrk family of protein kinases that includes Dyrk1A, Dyrk1C, Dyrk2, Dyrk3, Dyrk4A, and Dyrk4B, and, unusually, this family retains the ability to autophosphorylate at a conserved tyrosine residue on the activation loop.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Dyrk1B is expressed in several different tumor types and appears to play a key role in maintaining cells in quiescence.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Amplification of Dyrk1B expression has been observed in a large subset of ovarian cancers when compared to normal tissue, and depletion of Dyrk1B levels sensitizes these lines to cisplatin treatment, possibly through elevated reactive oxygen species content.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Dyrk1B was also found to be highly expressed in osteosarcoma cell lines, and shRNA-mediated target knockdown led to a decrease in proliferation and induction of apoptosis across a range of tumor lines. Osteosarcoma tumors display high metastatic potential, and the relative level of Dyrk1B expression has been correlated with poor outcome in such patients.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Additionally, a recent study has implicated a mutation in Dyrk1B kinase with increased adipogenesis and glucose homeostasis in an inherited form of metabolic syndrome.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Inhibition of Dyrk1A, by contrast, has been investigated as a strategy for therapeutic intervention in Down’s syndrome,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> where overexpression of the Dyrk1A gene on chromosome 21 has been linked to the impaired neuronal development associated with this genetic disorder through studies in rodents.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">Our interest in this kinase was linked to the observation that Dyrk1B is regulated by the kinase Erk and that inhibition of this pathway under serum-free conditions by treatment with a MEK inhibitor caused upregulation of Dyrk1B by 18–20-fold.<a onclick="showRef(event, 'cit1a'); return false;" href="javascript:void(0);" class="ref cit1a">(1a)</a> In-house studies confirmed upregulation of Dyrk1B mRNA and protein levels when cells are treated with MEK inhibitors, consistent with the hypothesis that Dyrk1B may be a resistance mechanism in cells undergoing a stress response. After knockdown of Dyrk1B, A375 cells were treated with MEK inhibitors AZD6244<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> or AZD8330<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> for 48 h. Total levels of Dyrk1B protein were analyzed by western blot (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), showing that MEK inhibition causes significant upregulation of Dyrk1B and that this is reduced by prior treatment with siRNA to Dyrk1B. Approximately 60% knockdown of Dyrk1B protein was observed in these experiments. The resulting viability of cells was also evaluated, and it can be seen that treatment of A375 cells with either Dyrk1B siRNA or MEK inhibitor independently results in no appreciable effects on viability; however, the combination of the two results in a significant enhancement of cell death (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0015.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. MEK inhibitor treatment of A375 melanoma cells results in significant upregulation of Dyrk1b, which is reduced by siRNA targeting Dyrk1b. Western blot is representative of at least two separate experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0016.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. siRNA-mediated knockdown of DYRK1b increases cell death in AZD6244-treated A375 cells. The percentage of dead cells plotted is the mean and SEM from four separate experiments. Statistically significant differences, compared with control (scrambled) siRNA, are indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Despite this interesting biology, there remains a lack of highly potent and selective tool molecules with which to elucidate the role of Dyrk family kinases in a disease setting, particularly with regard to recapitulation of siRNA knockdown studies, and also ultimately as <i>in vivo</i> probes.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The beta-carboline alkaloid harmine <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) has been most studied in the context of Dyrk1A inhibition in a neuritogenesis setting, although this tool compound may be more accurately described as a mixed Dyrk1A and 1B inhibitor, with reported enzyme IC<sub>50</sub>’s of 33 and 166 nM, respectively. It has much lower potency against Dyrk2 (2 μM) and Dyrk4 (74 μM).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Despite its generally good selectivity across other kinases,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> the utility of harmine as a probe compound, particularly <i>in vivo</i>, may be limited by other off-target pharmacologies, which include cytotoxicity,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> PPARgamma induction,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and potent inhibition of monoamine oxidase A.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Herein, we report our studies aimed at generating potent and selective small molecule inhibitors of the Dyrk family enzymes, in particular Dyrk1B, for use as <i>in vivo</i> probes to further delineate the role of these targets in disease.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0017.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Literature reported inhibitor of Dyrk1A and Dyrk1B, harmine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35034" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35034" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Azaindole <b>2</b> was brominated at C-3 to give compound <b>3</b>, which was subsequently protected to give benzenesulfonyl azaindole <b>4</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Boronate ester <b>5</b> served as the key intermediate for all anilinopyrimidine inhibitors and was derived from <b>4</b> via coupling with bis(pinacolato)diboron. Capping of <b>5</b> with a sulfonyl group was required to ensure efficient coupling in the subsequent step, which, in the case of 2,4-dichloropyrimidine, occurred selectively at C-4 to give pyrimidine <b>6</b>. <i>N</i>-Methyl azaindole analogues were prepared from <b>6</b> in a sequence involving deprotection to give <b>7</b> and methylation to give chloropyrimidine <b>8</b>. Introduction of the 2-anilino moiety was realized under mild acid catalysis to give <b>19</b>. Styrene analogue <b>31</b> was obtained directly from <b>6</b> via Suzuki cross-coupling and deprotection of the azaindole <i>in situ</i>. A modified route was adopted for synthesis of 2-methylpyrimidine analogues <b>32</b> and <b>33</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Here, azaindole <b>2</b> was first acetylated to give <b>3</b>. Protection of the azaindole nitrogen to give <b>10</b> was followed by a short sequence to build up the pyrimidine ring directly. Reaction of <b>10</b> with DMF acetal to give <b>11</b> was followed by condensation with acetimidamide and resultant loss of the protecting group to yield 2-methylpyrimidine <b>32</b>. Alkylation of the azaindole nitrogen of <b>32</b> was achieved under Mitsunobu conditions to give benzyl analogue <b>33</b>.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Key 6-Azaindole Intermediates and Inhibitors <b>19</b> and <b>31</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Br<sub>2</sub>, NaHCO<sub>3</sub>, MeOH, 0 °C, 3 h; (ii) PhSO<sub>2</sub>Cl, aq. NaOH, TBAHS, DCM, 0 °C, 1 h; (iii) PdCl2(dppf), Bis(pinacolato)diboron, KOAc, DME, 80 °C, 18 h; (iv) Pd(PPh<sub>3</sub>)<sub>4</sub>, 2,4-dichloropyrimidine, aq. Na<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C, 1 h; (v) aq. Na<sub>2</sub>CO<sub>3</sub>, dioxane, 120 °C, 0.5 h; (vi) NaH, MeI, 0 °C, 2 h; (vii) <i>p</i>TSA, 2-methoxy-4-(4-methylpiperazin-1-yl)aniline, NMP, 200 °C, 2 h; (viii) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, <i>trans</i>-stilbeneboronic acid, K<sub>2</sub>PO<sub>4</sub>·H<sub>2</sub>0, 130 °C, 0.5 h, then aq. Na<sub>2</sub>CO<sub>3</sub>, 140 °C, 40 min.</p></p></figure><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Diverse Dyrk1B Inhibitors <b>32</b> and <b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) AcCl, AlCl<sub>3</sub>, 25 °C, 18 h; (ii) PhSO<sub>2</sub>Cl, aq. NaOH, TBAHS, DCM, 0 °C, 40 min; (iii) 1,1-di-<i>tert</i>-butoxy-<i>N</i>,<i>N</i>-dimethylmethanamine, DMF, 80 °C, 1 h; (iv) acetimidamide·HCl, KO-<i>t</i>-Bu, DMA, 150 °C, 1 h; (v) PhCH<sub>2</sub>OH, DIAD, PPh<sub>3</sub>, THF, 25 °C, 18 h.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">6-Azaindole Anilinopyrimidines as Inhibitors of Dyrk1B</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06448" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06448" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Kinases Dyrk1A, Dyrk2, and Dyrk3 were available to us for screening through our collaboration with the MRC Protein Phosphorylation Unit at the University of Dundee together with a range of other serine–threonine kinases. This panel of enzymes was utilized by discovery projects to assess broader kinase selectivity as part of the lead optimization process. Consequently, there existed a significant amount of data against these isoforms for current and past project compounds. Compound <b>18</b>, initially synthesized as part of an internal program to target IGF, had been profiled in this panel and showed significant inhibition at 1 μM (90, 92, and 83% inhibition of Dyrk1A, 2, and 3, respectively), albeit with only a moderately selective profile. Of the 71 kinases tested in this panel, <b>18</b> showed >75% inhibition against 11 kinases (and >50% inhibition against 27/71). Internal testing confirmed <b>18</b> to be a highly potent inhibitor of Dyrk1B with an IC<sub>50</sub> of 4 nM. This initial lead compound was followed up with screening of further analogues, with the aim of improving the Dyrk1B potency and overall kinase selectivity and delivering tool molecules suitable for exploring the role of Dyrk1B inhibition <i>in vivo</i>.</div><div class="NLM_p">Compound <b>12</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), based on a 4,6-pyrimidine scaffold and an undecorated indole at C-4, has modest enzyme potency but weak activity in cells, with reasonable (28-fold) selectivity over IGF. Selectivity over cell cycle kinase CDK2 was also routinely assessed since compounds from this chemotype had provided the original leads for exploitation in IGF,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and <b>12</b> showed good selectivity over CDK2. Introduction of a 6-aza substituent to the indole as in <b>13</b>, however, has a dramatic effect on Dyrk1B potency, increasing 40-fold to 2 nM, and is suggestive of a specific interaction within the kinase active site. This change also appears to be highly unfavorable in IGF: the compound is inactive up to 100 μM, although selectivity against CDK2 is slightly reduced. Comparison of the <i>in vivo</i> clearances of these two compounds indicates exceptionally high clearance for the aza-analogue, which is not explained from <i>in vitro</i> clearance values, suggestive of an extrahepatic component to clearance. Introduction of an ortho-methoxy group at the hinge aniline, as in <b>14</b>, maintains Dyrk1B potency and improves selectivity over CDK2. The impact of an ortho-substituent in diminishing CDK2 potency has been documented,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and because such a strategy had previously been employed by us to gain CDK2 selectivity in the IGF targeting series, it is unsurprising to see measurable, albeit weak, IGF inhibition for this change. <i>In vivo</i> clearance for this compound again remains above liver blood flow, however. The much increased enzyme potency for <b>13</b> and <b>14</b> results in submicromolar cellular activity for these agents. Conversion of the basic side chain in <b>14</b> to a neutral, acetoxy-capped piperazine, as in <b>15</b>, was investigated because the transition from a basic to a neutral chemotype in optimization of the IGF series was commensurate with significantly improved DMPK. In the case of <b>15</b>, unfortunately, <i>in vivo</i> clearance remained stubbornly high and was coupled with a slight attenuation of Dyrk1B potency. Methylation of <b>15</b> to give <b>16</b> was undertaken in an effort to understand the role, if any, of the azaindole NH on clearance. Gratifyingly, <i>in vivo</i> clearance was observed to drop significantly to a more acceptable 16 mL/min/kg for this compound, with a slight drop in potency relative to that of <b>15</b> (2-fold). However, when dosed orally, <b>16</b> exhibited a low bioavailability of 5%, consistent with poor absorption. Transformation of 4,6-pyrimidine <b>15</b> to the matched 2,4-pyrimidine <b>17</b> highlights the role the hinge binding group plays in both potency and selectivity. Dyrk1B inhibition is similar for both scaffolds, but this compound, as expected, shows much greater activity versus IGF and CDK2. The <i>in vivo</i> clearance of <b>17</b> appears lower compared to that of <b>15</b>, although it is still in excess of liver blood flow. Finally, reversion of the side chain back to a basic piperazine, as in <b>18</b>, gives a highly potent Dyrk1B inhibitor with potent inhibition in cells, with an IC<sub>50</sub> of 85 nM. IGF and CDK2 appear to be largely indifferent to this change, resulting in an improved selectivity margin for <b>18</b>. Compound <b>18</b> is the pyrimidine matched pair to <b>14</b>; this switch to a 2,4-pyrimidine again confirms the largely similar Dyrk1B profile but with attenuated selectivity versus IGF and CDK2.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Profile of Anilinopyrimidine Inhibitors of Dyrk1B</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0007.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0008.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">All IC<sub>50</sub> data are reported as micromolar and are the mean of at least <i>n</i> = 2 independent measurements. Each has a SEM ± 0.2 log units.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Inhibition of phosphorylation of Dyrk pS421 of transiently overexpressed cMyc-Dyrk in Cos-1 cells following a 5 h treatment with compound.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Cl<sub>int</sub> (μL/min/1 × 10<sup>6</sup> cells) in Wistar Han rat hepatocytes.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Plasma Cl (mL/min/kg) in Wistar Han rats dosed at 2 μmol/kg.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Bioavailability of an oral solution in Wistar Han rats dosed at 3 μmol/kg.</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">Blood Cl.</p></div></div><div></div></div><div class="NLM_p">This initial exploration highlighted the azaindole moiety as the likely cause of the high observed <i>in vivo</i> clearance, particularly in light of the lowered clearance with indole <b>12</b> and methylated azaindole <b>16</b>. As it appeared that both an azaindole and basic side chain are required for high potency, we further examined the role of substitution on the heterocycle to modulate metabolism (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). <i>N</i>-Methyl azaindole <b>19</b>, the basic analogue of <b>16</b>, is a potent inhibitor of Dyrk1B kinase with good selectivity over IGF and CDK2. As with <b>16</b>, this compound showed low <i>in vitro</i> and <i>in vivo</i> clearance in rat and, gratifyingly, an improved, yet modest, bioavailability of 22%. It is tempting to speculate that the reduced bioavailability seen with neutral <b>16</b> is as a consequence of its much reduced aqueous solubility (pH 7.4) relative to that of <b>19</b> (53 versus >755 μM, respectively). Methylation adjacent to the aza-nitrogen at C5 to give <b>20</b>, or C7 to give <b>21</b>, gave compounds with very low turnover in rat hepatocytes, although in both of these compounds, potent IGF inhibition was observed. Consistent with earlier compounds, and despite low clearance <i>in vivo</i> for <b>21</b>, no oral exposure was seen for this compound where the azaindole nitrogen was not methylated. Combining the features of <b>19</b> and <b>21</b> to give dimethylated azaindole <b>22</b> gave a low clearance compound with the selectivity profile somewhat restored, although bioavailability was lower at 14%, again possibly a consequence of lower solubility (4 μM).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Profile of Methylated Azaindole Inhibitors of Dyrk1B</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0009.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">IC<sub>50</sub> (μM)</th><th class="rowsep1 colsep0" colspan="3" align="center">Rat DMPK</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ID</th><th class="colsep0 rowsep0" align="center">R1</th><th class="colsep0 rowsep0" align="center">R2</th><th class="colsep0 rowsep0" align="center">R3</th><th class="colsep0 rowsep0" align="center" char=".">Dyrk1B<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">Cell<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">IGF<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">CDK2<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">Cl<sub>int</sub><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">Cl<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">F%<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.042</td><td class="colsep0 rowsep0" align="char" char=".">0.779</td><td class="colsep0 rowsep0" align="char" char=".">4.473</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.072</td><td class="colsep0 rowsep0" align="char" char=".">10.476</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">0.083</td><td class="colsep0 rowsep0" align="char" char=".">0.051</td><td class="colsep0 rowsep0" align="char" char=".">17.368</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">0.168</td><td class="colsep0 rowsep0" align="char" char=".">3.174</td><td class="colsep0 rowsep0" align="char" char=".">13.713</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">14</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">All IC<sub>50</sub> data are reported as micromolar and are the mean of at least <i>n</i> = 2 independent measurements. Each has a SEM ± 0.2 log units.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Inhibition of phosphorylation of Dyrk pS421 of transiently overexpressed cMyc-Dyrk in Cos-1 cells following a 5 h treatment with compound.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Cl<sub>int</sub> (μL/min/1 × 10<sup>6</sup> cells) in Wistar Han rat hepatocytes.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Plasma Cl (mL/min/kg) in Wistar Han rats dosed at 2 μmol/kg.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">Bioavailability of an oral solution in Wistar Han rats dosed at 3 μmol/kg.</p></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Structural Basis for Potency and Selectivity</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45340" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45340" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Insights into the binding mode of the series benefited from the solved kinase crystal structures of closely related compound <b>23</b> in both TTK and IGF1R (Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), which had been solved in-house previously (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4D2S">4D2S</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4D2R">4D2R</a>, respectively). This compound exhibited an IC<sub>50</sub> of 0.02 μM against TTK and 3.3 μM against IGF1R in biochemical assays, allowing these systems to act as potential structural surrogates. The Dyrk1B potency of this compound was 0.14 μM. The template binds in a traditional anilino-pyrimidine binding mode with a hydrogen-bond acceptor–donor pair interaction with the hinge region of each kinase, Gly-605 in TTK and Met-1082 in IGF1R. The basic piperidine side chain on the anilino group is directed into the solvent channel, as is commonly observed in kinase inhibitor bound crystal structures. Interactions in this region can impact inhibitor potency and selectivity but most notably allow for modulation of physical properties. Interestingly, there appear to be differences in the binding mode conformation of the 6-azaindole group between the two structures. The IGF1R structure shows the 6-azaindole group directed back toward the solvent-exposed region of the pocket; the azaindole itself does not appear to make any specific interactions to explain the role of the nitrogen on the azaindole ring. Conversely, in the TTK structure, this group is directed toward the selectivity pocket region and the aza-nitrogen appears to make a specific interaction with the conserved lysine residue (Lys-553) that is present in most kinases. It is perhaps nonintuitive that making a specific interaction with this lysine residue would lead to improved selectivity; it is, however, likely that the environment around the lysine is variable across the kinome, and the ability of the azaindole group to bind may vary between different kinases. The increased potency of compound <b>23</b> in TTK (and selectivity versus IGF1R) may initially suggest this binding mode is also the preferred one in Dyrk1B. However, we additionally observed that introduction of a 5-chloro group to the pyrimidine template, as in compound <b>24</b>, maintains potency in Dyrk1B (IC<sub>50</sub> of 0.025 μM) but shows much reduced selectivity (with IC<sub>50</sub>’s of 0.02 μM in CDK2 and 0.03 μM in IGF1R). The addition of this chlorine would be expected to cause a steric clash with the 6-azaindole and enforce a binding mode similar to the IGF1R structure, explaining the lowered selectivity. The presence of the chlorine itself may also increase the potency of compound <b>24</b> against other kinases directly, especially kinases with lipophilic gatekeeper residues such as methionine, which is the gatekeeper of IGF1R, the original target of this series. That Dyrk1B potency is maintained with both a 5-H and 5-Cl pyrimidine may support a hypothesis that the preferred Dyrk1B binding mode to gain selectivity is as observed in TTK, but that the alternative, IGF1R-like, binding mode is also tolerated in Dyrk1B if additional substituents prohibit access to the more selective TTK orientation.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0018.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structures of compound <b>23</b> bound in IGF1R (pink) and TTK (cyan) showing the change in orientation of the C-4 azaindole headgroup.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0019.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compounds used to infer the binding mode of azaindoles in Dyrk1B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further develop our understanding of the binding modes of these compounds, a number of kinases were identified that had homologous kinase domain sequences. At the time this work was undertaken, there were no published Dyrk family crystal structures available; therefore, of most interest were kinases that were likely to share structural similarity to Dyrk1B in the ATP pocket. The published CLK1 structure bound with 10z-hymenialdisine <b>25</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z57">1Z57</a>; Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) appeared to provide a suitable structural surrogate with ∼92% sequence homology to Dyrk1B in the ATP pocket, although the overall sequence homology was only ∼31%. Interestingly, the aminoimidazolone group of <b>25</b> directly interacts with the conserved lysine (Lys-191), as is similarly observed for the 6-azaindole group of compound <b>23</b> in the TTK structure. Additionally, the carbonyl group of Leu-244 on the hinge is observed with a pronounced twist, resulting in this group being less accessible to an inhibitor relative to that which is commonly observed across kinases. The equivalent carbonyl group was shown to form a direct hydrogen bond with the C-2 anilino group of <b>23</b> in both the IGF1R and TTK structures, but this interaction appeared unlikely to be optimal if this more signficant twist was observed in Dyrk1B. In addition, the sequence overlay of CLK1 with Dyrk1B highlights a leucine residue in Dyrk1B in the same position as Leu-244 of CLK1. We therefore speculated that Dyrk1B may accommodate a greater variety of functionality in this position, more specifically agents lacking a donor in the established 1,3-donor–acceptor hinge interaction.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0001.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structure of 10z-hymenialdisine <b>25</b> bound to CLK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Wider testing of kinase templates from our screening collection that lacked the hydrogen-bond donor in this position identified a published MK2 inhibitor, <b>26</b>,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> which, in our hands, had an IC<sub>50</sub> 0.043 μM in Dyrk1B. A crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P3G">2P3G</a>) of a compound from this series bound in MK2 confirms interaction with the hinge region via the pyridine, with the C-2 phenyl ring passing close to the hinge region and directed toward solvent. It is also interesting to note that this molecule appears to interact with the conserved lysine (Lys-93) of MK2 (and therefore most likely Dyrk1B also) in a similar fashion as that of compound <b>23</b> in TTK through the amide of the C-4 group. Subsequent to this work, crystal structures of Dyrk1A have been released into the public domain, and one example is bound with harmine <b>1</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ANR">3ANR</a>; Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). This structure shows the inhibitor interacting with the salt bridge (Lys-188) via the pyridine group, again reminiscent of the interaction of the 6-azaindole with this group in the TTK structure, and provides further evidence to support the proposed binding mode of this series in Dyrk1B. Harmine appears to interact with the hinge region via a hydrogen-bond acceptor from the methoxy group to the backbone of Leu-241. Gratifyingly, this structure also demonstrates the twist of the carbonyl in the hinge region that we had predicted and suggests that such a feature is likely to be observed in Dyrk1B also. Reviewing the psi angle from the carbonyl across the kinase structures described, IGF1R showed ψ = −92.6°, TTK, ψ = −17.2°, CLK1, ψ = 0.2°, and Dyrk1A, ψ = 6.7°. This highlights the most significant twist was observed in the CLK1 and Dyrk1A structures, although the TTK structure also showed the carbonyl to be out-of-plane relative to IGF1R (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0002.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Crystal structure of harmine <b>1</b> bound to Dyrk1A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0003.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structure of 10z-hymenialdisine <b>25</b> bound to CLK1 (orange) overlaid with compound <b>23</b> bound in IGF1R (pink). The atoms used in the measurement of the psi torsion are indicated in bold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Such subtle differences in hinge region conformation appear to allow selectivity to be achieved across certain kinases. A more significant conformational change in the hinge region has been reported in P38α, where a flip of the hinge region residues Leu-108 and Met-109, which changes the interaction pattern of the hinge, led to the identification of inhibitors with increase selectivity.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">A Hybrid 2-Phenylpyrimidine Series</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15656" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15656" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Hybridization of the favored Dyrk1B azaindole pharmacophore with reported MK2 inhibitor <b>26</b>, in a manner that places a direct phenyl group linked to the C-2 position of the pyrimidine hinge binder, gave <b>27</b>. As hypothesized, deletion of the hinge hydrogen-bond donor was tolerated and led to potent inhibition of Dyrk1B (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Selectivity against IGF and CDK2 was also improved, and it was anticipated that wider kinase selectivity would also be enhanced. Further optimization of <b>27</b> was undertaken, with an emphasis on reducing lipophilicity. Replacement of the terminal amide of <b>27</b> with a methanesulfonyl moiety gave <b>28</b>, which showed modest cellular activity but with excellent selectivity. Despite this, <i>in vitro</i> clearance was high in rat hepatocytes. Building upon the SAR for methyl substitution on the azaindole delineated earlier for the anilinopyrimidine series, <i>N</i>-Methyl analogue <b>29</b> and C7-Methyl analogue <b>30</b> were also synthesized. Compound <b>29</b> with submicromolar cellular potency and increased selectivity versus IGF and CDK2 benefited from low <i>in vitro</i> and <i>in vivo</i> turnover and a reasonable bioavailability of 37%. Unlike that in the aniline series, the low solubility of <b>29</b> (2 μM) did not preclude good absorption, presumably due to the excellent permeability as measured in Caco2 cells. The C7-Methyl analogue <b>30</b> had a similar overall profile, albeit with reduced potency and compromised bioavailability, which is consistent with the <i>in vivo</i> profile of this headgroup in compound <b>21</b>, the equivalent compound in the aniline series.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. 2-Phenylpyrimidine Inhibitors of Dyrk1B</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0010.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">IC<sub>50</sub> (μM)</th><th class="rowsep1 colsep0" colspan="3" align="center">Rat DMPK</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ID</th><th class="colsep0 rowsep0" align="center">R1</th><th class="colsep0 rowsep0" align="center">R2</th><th class="colsep0 rowsep0" align="center">R3</th><th class="colsep0 rowsep0" align="center" char=".">Dyrk1B<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">Cell<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">IGF<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">CDK2<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">Cl<sub>int</sub><a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">Cl<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">F%<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">C(O)NH-c-Pentyl</td><td class="colsep0 rowsep0" align="char" char=".">0.098</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">67.727</td><td class="colsep0 rowsep0" align="left">45.885</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="char" char=".">0.021</td><td class="colsep0 rowsep0" align="char" char=".">0.898</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">16.884</td><td class="colsep0 rowsep0" align="left">129</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="char" char=".">0.012</td><td class="colsep0 rowsep0" align="char" char=".">0.810</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="char" char=".">0.014</td><td class="colsep0 rowsep0" align="char" char=".">2.118</td><td class="colsep0 rowsep0" align="left">>29</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">All IC<sub>50</sub> data are reported as micromolar and are the mean of at least <i>n</i> = 2 independent measurements. Each has a SEM ± 0.2 log units.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Inhibition of phosphorylation of Dyrk pS421 of transiently overexpressed cMyc-Dyrk in Cos-1 cells following a 5 h treatment with compound.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Cl<sub>int</sub> (μL/min/1 × 10<sup>6</sup> cells) in Wistar Han rat hepatocytes.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Plasma Cl (mL/min/kg) in Wistar Han rats dosed at 2 μmol/kg.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">Bioavailability of an oral solution in Wistar Han rats dosed at 3 μmol/kg.</p></div></div></div><div class="NLM_p">Encouraged by the unusual observation that the donor can be dispensed with in the usual donor–acceptor hinge interaction of this anilinopyrimidine series, we sought to further explore the tolerance for functionality in this region. Extending the aromatic group at C-2 out by spacing with a <i>trans</i>-alkene gave compound <b>31</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), which was a potent inhibitor of Dyrk1B in enzyme and cell assays, with good selectivity versus IGF and CDK2. Compound <b>32</b> indicates that substantial activity is retained in this template even when the C-2 group is pared to as small a group as methyl. Inhibitor <b>32</b>, with a molecular weight of just 210 Da, represents a highly ligand efficient (LE), almost fragment like, yet potent inhibitor of Dyrk1B enzyme with an IC<sub>50</sub> of 0.017 μM (LE defined as pIC<sub>50</sub>/heavy atom count = 0.49). Alkylation of <b>32</b> with a benzyl group gave <b>33</b>, which recovered a significant amount of the cellular potency lost in compound <b>32</b> and illustrates the scope for additional optimization in this region of the binding site. Finally, in exploration of alternative hinge binding motifs, compound <b>34</b>, a structurally interesting fusion of 6- and 7-azaindole moieties, also represents a highly potent scaffold for Dyrk1B inhibition. In this case, restoration of the 1,3-donor–acceptor motif leads to increased CDK2 inhibition, however.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. 2-Alkylpyrimidine Inhibitors of Dyrk1B</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0011.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0012.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">All IC<sub>50</sub> data are reported as micromolar and are the mean of at least <i>n</i> = 2 independent measurements. Each has a SEM ± 0.2 log units.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Inhibition of phosphorylation of Dyrk pS421 of transiently overexpressed cMyc-Dyrk in Cos-1 cells following a 5 h treatment with compound.</p></div></div><div></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Selectivity Profiles</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88552" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88552" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To assess the broader kinase selectivity of the Dyrk inhibitors, representative compounds were screened in a diverse panel of 124 kinases at a single concentration of 1 μM. Inhibitors <b>19</b>, <b>31</b>, and <b>33</b> were chosen as being a potent, structurally diverse set, representing examples from the anilinopyrimidine and hybrid series, and the kinome profile of these compounds is shown in summary form in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. Complete panel data is available as <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>. Generally, all compounds showed a reasonable selectivity profile. Anilinopyrimidine <b>19</b> showed a moderately selective profile, although it was the least selective of the three, with 10% of the panel inhibited >75%. Hybrid <b>33</b> appeared to be the most selective of these, with no kinases inhibited above the 50% level. By comparison, hybrid <b>31</b> was slightly less selective, and it is tempting to speculate that an alternative binding modality through the azaindole nitrogen acceptor might be accessible for some of the kinases inhibited by this compound. It was determined that compound <b>19</b> was also able to potently inhibit other Dyrk family members, albeit with selectivity in favor of Dyrk1B (IC<sub>50</sub>’s of 3, 30, and 190 nM against Dyrk1B, Dyrk1A, and Dyrk2, respectively).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Kinase Selectivity Profiles of Representative Dyrk1B Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ID</th><th class="colsep0 rowsep0" align="center">percent kinases inhibited >75%</th><th class="colsep0 rowsep0" align="center">percent kinases inhibited >50%</th><th class="colsep0 rowsep0" align="center">kinases most potently inhibited</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">CaMKIIβ, Flt3, DRAK1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">Flt1, Flt3, MLK1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Mnk2, PI3KC2γ, Flt3</td></tr></tbody></table></div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Cellular Profiling</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17306" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17306" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A primary hypothesis was developed that a Dyrk1B inhibitor in combination with a MEK inhibitor would result in increased cell death in solid tumors, with melanoma being an example of a tumor type where a strong response might be expected. It was observed that tumor cells upregulate Dyrk1B in response to MEK inhibitors and that siRNA to Dyrk1B sensitized multiple tumor cell lines to MEK inhibitors, including induction of cell death in the most sensitive models. A selection of potent, structurally diverse Dyrk1B inhibitors assembled in the course of this study was profiled in A375 melanoma cells in combination with MEK inhibitor AZD6244 (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). The combination of MEK inhibitor and siRNA leads to an increase in cell death over that with either modality alone. In contrast to this, we observed no effect of structurally diverse and potent Dyrk1B inhibitors <b>19</b>, <b>31</b>, and <b>33</b> in combination with MEK inhibitor in this assay. It is noteworthy that <b>33</b>, shown to be a highly selective inhibitor of Dyrk1B, with cellular activity, showed no effect in sensitization. Taken together, we conclude that Dyrk1B kinase inhibition with a small molecule ATP competitive inhibitor does not recapitulate the effects seen in combination with target knockdown through siRNA. That gene silencing through target knockdown leads to a different phenotype from that seen with small molecule inhibition is perhaps not unexpected, since the former may disrupt critical protein complexes or inhibit other functional activities independent of kinase activity.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Compound <b>19</b> has recently been profiled in depth for its role in inhibiting Dyrk1B in a cellular setting and was shown to potently inhibit Dyrk1B induced phosphorylation of cyclin D1 at T286.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Dyrk1B is also known to autophosphorylate at Y273, and, in contrast, this activity is not abolished by either compound <b>19</b> or, indeed, harmine <b>1</b>. This is one example of a functionally different consequence from that observed with gene knockdown approaches, but it is not possible to attribute with certainty the lack of observed sensitization to MEK inhibition to this specific observation.</div><figure id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0004.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Impact on survival of the combination of MEK inhibitor AZD6244 and Dyrk1B inhibition on A375 melanoma cell line. Dyrk1B inhibition is affected with inhibitors <b>19</b>, <b>31</b>, and <b>33</b>. A375 cells were treated with AZD6244 in the presence or absence of DYRK1b inhibitors <b>19</b>, <b>31</b>, or <b>33</b> at a concentration of 1.33 μM for 72 h. The viability of cells was evaluated using CellTraceTM calcein green AM and propidium iodide (PI) stains. The percentage of dead cells plotted is the mean and SEM from at least two separate experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48082" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48082" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Treatment of a variety of cell lines either with a MEK inhibitor or under conditions of serum starvation leads to significant upregulation of Dyrk1B, and combination of this with silencing of Dyrk1B leads to enhanced cell death. A diverse array of potent, selective, and cellular active Dyrk1B inhibitors has been developed through a combination of targeted screening and structure-based design, but these do not recapitulate the sensitization seen with siRNA. Nevertheless, these compounds may serve as useful tools to further delineate the role of Dyrk1B in cells and may provide useful tools in further exploring the role of the Dyrk family enzymes in an <i>in vivo</i> disease model setting.</div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61658" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61658" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec9_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemistry</h3><div class="NLM_p last">All reactions were performed under inert conditions (nitrogen) unless otherwise stated. Temperatures are given in degrees celsius (°C); operations were carried out at room or ambient temperature, that is, at a temperature in the range of 18–25 °C. All solvents and reagents were purchased from commercial sources and used without further purification. For coupling reactions, all solvents were dried and degassed prior to reaction. Reactions performed under microwave irradiation utilized either a Biotage Initiator or CEM Discover microwave. Upon work up, organic solvents were typically dried prior to concentration with anhydrous MgSO<sub>4</sub> or Na<sub>2</sub>SO<sub>4</sub>. Flash silica chromatography was typically performed on an Isco Companion, using Silicycle silica gel, 230–400 mesh 40–63 μm cartridges, Grace Resolv silica cartridges or Isolute Flash Si or Si II cartridges. Reverse-phase chromatography was performed using a Waters XBridge Prep C18 OBD column, 5 μ silica, 19 mm diameter, 100 mm length, using decreasingly polar mixtures of either water (containing 1% NH<sub>3</sub>) and acetonitrile or water (containing 0.1% formic acid) and acetonitrile as eluents. Analytical LC-MS was performed on a Waters 2790 LC with a 996 PDA and 2000 amu ZQ single quadrupole mass spectrometer using a Phenomenex Gemini 50 × 2.1 mm 5 μm C18 column; UPLC was performed on a Waters Acquity binary solvent manager with Acquity PDA and an SQD mass spectrometer using a 50 × 2.1 mm 1.7 μm BEH column from Waters, and purities were measured by UV absorption at 254 nm or TIC and are ≥95% unless otherwise stated. NMR spectra were recorded on a Bruker Av400 or Bruker DRX400 spectrometer at 400 MHz in DMSO-<i>d</i><sub>6</sub> at 303 K unless otherwise indicated. <sup>1</sup>H NMR spectra are reported as chemical shifts in parts per million (ppm) relative to an internal solvent reference. Yields are given for illustration only and are not necessarily those which can be obtained by diligent process development; preparations were repeated if more material was required.</div></div><div id="sec9_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 3-Bromo-1<i>H</i>-pyrrolo[2,3<i>-c</i>]pyridine (<b>3</b>)</h3><div class="NLM_p last">A solution of bromine (8.7 mL, 169 mmol) in methanol (300 mL) was added dropwise to a stirred mixture of 1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine <b>2</b> (20 g, 169 mmol) and sodium hydrogen carbonate (42.7 g, 508 mmol) in methanol (600 mL) at −5 °C at such a rate that the internal temperature remained below 0 °C. The resulting mixture was allowed to warm to room temperature and stirred for 3 h. The reaction mixture was evaporated to dryness, redissolved in ethyl acetate (1 L), and washed sequentially with water (2 × 1 L) and saturated brine (1 L). The organic layer was dried, filtered, and evaporated to afford crude product. The crude product was purified by recrystallization from toluene (1 L) to afford <b>3</b> (17.7 g, 53%) as a beige solid. <sup>1</sup>H NMR δ 7.41 (1H, dd), 7.81 (1H, s), 8.21 (1H, d), 8.78 (1H, d), 11.98 (1H, brs); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 199; HPLC <i>t</i><sub>R</sub> = 1.57 min.</div></div><div id="sec9_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 3-Bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine (<b>4</b>)</h3><div class="NLM_p last">Benzenesulfonyl chloride (13.7 mL, 108 mmol) was added dropwise to compound <b>3</b> (17.7 g, 90 mmol), tetrabutylammonium hydrogensulfate (0.9 g, 2.7 mmol) in dichloromethane (200 mL), and sodium hydroxide (10.78 g, 269 mmol) in water (20 mL) at 0 °C over a period of 5 min. The resulting mixture was stirred at 0 °C for 1 h. The reaction mixture was diluted with dichloromethane (100 mL) and washed with water (2 × 100 mL). The organic layer was dried, filtered, and evaporated to afford crude product, which was triturated with methanol to give a solid that was collected by filtration and dried under vacuum to give <b>4</b> (23.8 g, 78%) as a beige powder. <sup>1</sup>H NMR δ 7.53 (1H, dd), 7.61–7.69 (2H, m), 7.72–7.79 (1H, m), 8.12–8.18 (2H, m), 8.44 (1H, s), 8.51 (1H, d), 9.28 (1H, d); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 339; HPLC <i>t</i><sub>R</sub> = 2.38 min.</div></div><div id="sec9_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 1-(Phenylsulfonyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine (<b>5</b>)</h3><div class="NLM_p last">PdCl<sub>2</sub>(dppf) (1.3 g, 1.8 mmol) was added in one portion to 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) (5.4 g, 21 mmol), compound <b>4</b> (6 g, 17.8 mmol), and potassium acetate (5.9 g, 60.5 mmol) in dimethoxyethane (170 mL) at 25 °C under nitrogen. The resulting mixture was stirred at 80 °C for 18 h. The reaction mixture was evaporated to dryness and dissolved in ethyl acetate (600 mL), water was added (500 mL), and the mixture was shaken and filtered through dicalite. The ethyl acetate layer was separated and washed with saturated brine (500 mL). The organic layer was dried and filtered. This was poured onto a plug of silica and eluted with ethyl acetate (1.5 L) to give a pink solid, which was triturated with diethyl ether to afford <b>5</b> (5.2 g, 76%) as a white solid. <sup>1</sup>H NMR δ 1.33 (12H, s), 7.65 (2H, t), 7.73–7.80 (2H, m), 8.18–8.25 (3H, m), 8.43 (1H, d), 9.24 (1H, d); <i>m</i>/<i>z</i> (ESI+) (M + H)<sup>+</sup> = 303; HPLC <i>t</i><sub>R</sub> = 0.83 min.</div></div><div id="sec9_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 3-(2-Chloropyrimidin-4-yl)-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine (<b>6</b>)</h3><div class="NLM_p last">Tetrakis(triphenylphosphine)palladium(0) (0.78 g, 0.7 mmol) was added in one portion to 2,4-dichloropyrimidine (3 g, 20 mmol), compound <b>5</b> (5.2 g, 13.5 mmol), and 2 M sodium carbonate (27 mL, 54 mmol) in dioxane (80 mL) at 25 °C under nitrogen. The resulting mixture was stirred at 80 °C for 1 h. The reaction mixture was allowed to cool and then quenched with water (750 mL), and the precipitate was collected by filtration, washed with water, and dried under vacuum to afford crude product as a green solid. This was preadsorbed onto silica and purified by flash silica chromatography (elution gradient 0–100% ethyl acetate in isohexane). Pure fractions were evaporated to dryness to afford <b>6</b> (1.33 g, 27%) as a yellow solid. <sup>1</sup>H NMR δ 7.64–7.71 (2H, m), 7.75–7.81 (1H, m), 8.19–8.26 (2H, m), 8.29 (1H, d), 8.39 (1H, dd), 8.57 (1H, d), 8.82 (1H, d), 9.23 (1H, s), 9.32 (1H, d); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 371; HPLC <i>t</i><sub>R</sub> = 2.35 min.</div></div><div id="sec9_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 3-(2-Chloropyrimidin-4-yl)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine (<b>7</b>)</h3><div class="NLM_p last">Compound <b>6</b> (1.26 g, 3.4 mmol) and 2 M aqueous sodium carbonate (8.5 mL, 17 mmol) were suspended in dioxane (80 mL) and sealed into a microwave tube. The reaction was heated at 120 °C for 30 min in the microwave reactor and cooled to room temperature. The mixture was diluted with water (80 mL), and the organic solvent was removed by rotary evaporation. This gave a solid that was collected by filtration and dried under vacuum to give <b>7</b> (0.8 g, 100%) as a yellow solid. <sup>1</sup>H NMR δ 7.97 (1H, d), 8.29 (1H, dd), 8.33 (1H, d), 8.61 (1H, d), 8.70 (1H, s), 12.53 (1H, brs); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 231; HPLC <i>t</i><sub>R</sub> = 2.16 min.</div></div><div id="sec9_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 3-(2-Chloropyrimidin-4-yl)-1-methyl-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine (<b>8</b>)</h3><div class="NLM_p last">Sodium hydride (151 mg, 3.8 mmol) was added in one portion to compound <b>7</b> (790 mg, 3.4 mmol) in DMF (20 mL) at 0 °C under nitrogen. The resulting mixture was stirred at 0 °C for 30 min, and then iodomethane (0.22 mL, 3.6 mmol) was added dropwise. The mixture was stirred and allowed to warm to ambient temperature over 2 h. The reaction mixture was diluted with ethyl acetate (100 mL) and washed sequentially with water (3 × 100 mL) and saturated brine (100 mL). The organic layer was dried, filtered, and evaporated to afford crude product, which was purified by flash silica chromatography (elution gradient 0–5% 7 M ammonia/methanol in dichloromethane). Pure fractions were evaporated to dryness to afford <b>8</b> (146 mg, 17%) as a yellow solid. <sup>1</sup>H NMR δ 4.02 (3H, s), 7.88 (1H, d), 8.27 (1H, dd), 8.38 (1H, d), 8.62 (1H, d), 8.68 (1H, s), 8.98 (1H, d); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 245; HPLC <i>t</i><sub>R</sub> = 2.29 min.</div></div><div id="sec9_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>N</i>-(2-Methoxy-4-(4-methylpiperazin-1-yl)phenyl)-4-(1-methyl-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridin-3-yl)pyrimidin-2-amine (<b>19</b>)</h3><div class="NLM_p last">2-Methoxy-4-(4-methylpiperazin-1-yl)aniline (132 mg, 0.6 mmol), compound <b>8</b> (73 mg, 0.3 mmol) and 4-methylbenzenesulfonic acid hydrate (170 mg, 0.9 mmol) were dissolved in NMP (3 mL) and sealed into a microwave tube. The reaction was heated at 200 °C for 2 h and cooled. The reaction mixture was diluted with water, and saturated sodium bicarbonate was added. This was extracted with ethyl acetate, and the combined organic extracts were washed with water and saturated brine. The organic layer was dried, filtered, and evaporated to afford crude product, which was purified by flash silica chromatography (elution gradient 0–6% 7 N ammonia/methanol in dichloromethane). Pure fractions were evaporated to dryness to afford <b>19</b> (30 mg, 23%) as a solid. <sup>1</sup>H NMR δ 2.26 (3H, s), 2.48–2.54 (4H, m), 3.17 (4H, t), 3.81 (3H, s), 3.98 (3H, s), 6.56 (1H, dd), 6.68 (1H, d), 7.12 (1H, d), 7.71 (1H, d), 7.95 (1H, s), 8.18–8.25 (2H, m), 8.28 (1H, d), 8.44 (1H, s), 8.90 (1H, s); HRMS: ESI<sup>+</sup><i>m</i>/<i>z</i> calcd, 430.2277; found, 430.23438 (M + H)<sup>+</sup>; HPLC <i>t</i><sub>R</sub> = 2.86 min.</div></div><div id="sec9_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (<i>E</i>)-3-(2-Styrylpyrimidin-4-yl)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine (<b>31</b>)</h3><div class="NLM_p last">Tetrahydrofuran (2.15 mL) was added in one portion to <i>trans</i>-beta-styreneboronic acid (0.048 g, 0.32 mmol), compound <b>6</b> (0.1 g, 0.27 mmol), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (9.5 mg, 0.01 mmol), and <i>tri</i>-potassium phosphate trihydrate (0.11 g, 0.54 mmol) at 25 °C and sealed into a microwave tube. The reaction was heated at 130 °C for 30 min in the microwave reactor and cooled. 2 N sodium carbonate (600 μL) was added to the reaction and sealed into a microwave tube. The reaction was heated at 140 °C for 1 h and cooled. The reaction was evaporated to dryness, and DMF (3 mL) was added, the mixture was filtered, and the filtrate was purified by preparative HPLC using decreasingly polar mixtures of water (containing 1% ammonia) and acetonitrile as eluents. Fractions containing the desired compound were evaporated to dryness, and the material was further purified by ion exchange chromatography, using a 1g SCX-3 column. The desired product was eluted from the column using 7 M ammonia in methanol, and pure fractions were evaporated to dryness to afford <b>31</b> (0.03 g, 39%) as a solid. <sup>1</sup>H NMR δ 7.41 (1H, d), 7.42–7.55 (3H, m), 7.81–7.88 (3H, m), 8.09 (1H, d), 8.39 (1H, d), 8.58 (1H, dd), 8.70 (1H, s), 8.74 (1H, d), 8.92 (1H, d), 12.38 (1H, s); HRMS: ESI<sup>+</sup><i>m</i>/<i>z</i> calcd, 298.1218; found, 299.12888 (M + H)<sup>+</sup>; HPLC <i>t</i><sub>R</sub> = 2.13 min.</div></div><div id="sec9_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 1-(1<i>H</i>-Pyrrolo[2,3-<i>c</i>]pyridin-3-yl)ethanone (<b>9</b>)</h3><div class="NLM_p last">Aluminum chloride (16.9 g, 127 mmol) was added in one portion to 1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine <b>2</b> (3 g, 25.39 mmol) in DCM (596 mL) at 25 °C under nitrogen. The resulting mixture was stirred at 25 °C for 1 h. To this was added acetyl chloride (9 mL, 127 mmol) dropwise over 15 min. The reaction mixture was stirred at 25 °C for 18 h under nitrogen. The reaction mixture was quenched with methanol (80 mL) dropwise (cautious) with cooling in a water bath. The reaction mixture was evaporated to dryness, dissolved in water, and purified by ion exchange chromatography, using an SCX-2 column, washing the column well with water and then MeOH. The desired product was eluted from the column using 7 M ammonia in methanol, and pure fractions were evaporated to dryness to afford <b>9</b> (3 g, 74%) as a yellow solid. <sup>1</sup>H NMR δ 2.49 (3H, s), 8.05 (1H, dd), 8.28 (1H, d), 8.49 (1H, s), 8.83 (1H, d), 12.32 (1H, s); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 160.79, HPLC <i>t</i><sub>R</sub> = 1.39 min.</div></div><div id="sec9_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 1-(1-(Phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridin-3-yl)ethanone (<b>10</b>)</h3><div class="NLM_p last">Benzenesulfonyl chloride (5.1 mL, 40 mmol) was added dropwise to compound <b>9</b> (5.3 g, 33 mmol), tetrabutylammonium hydrogensulfate (0.34 g, 1 mmol), sodium hydroxide (4 g, 100 mmol) in dichloromethane (100 mL), and water (20 mL) cooled to 0 °C over a period of 5 min. The resulting suspension was stirred at 0 °C for 40 min. The layers were separated, and the aqueous layer was extratced with dichloromethane (100 mL). The combined organic layers were then washed with water (100 mL) and concentrated to dryness. The crude residue was triturated with methanol to give a solid, which was collected by filtration and dried under vacuum to give <b>10</b> (5.8 g, 58%) as a white solid. <sup>1</sup>H NMR δ 2.61 (3H, s), 7.68 (2H, dt), 7.75–7.82 (1H, m), 8.10 (1H, dd), 8.25 (2H, dt), 8.49 (1H, d), 9.00 (1H, s), 9.25 (1H, d); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 301.09; HPLC <i>t</i><sub>R</sub> = 2.49 min.</div></div><div id="sec9_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (<i>E</i>)-3-(Dimethylamino)-1-(1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridin-3-yl)prop-2-en-1-one (<b>11</b>)</h3><div class="NLM_p last">1,1-Di-<i>tert</i>-butoxy-<i>N,N</i>-dimethylmethanamine (0.4 mL, 1.7 mmol) was added in one portion to compound <b>10</b> (100 mg, 0.33 mmol) in DMF (2 mL). The resulting solution was stirred at 80 °C for 2.5 h. The mixture was then concentrated to dryness and triturated with ether to give a dark green solid, which was purified by flash silica chromatography )elution gradient 0–10% methanol in dichloromethane). Pure fractions were evaporated to dryness to afford <b>11</b> (76 mg, 64%) as a yellow solid. <sup>1</sup>H NMR δ 2.98 (3H, s), 3.15 (3H, s), 5.96 (1H, d), 7.61–7.72 (3H, m), 7.77 (1H, t), 8.12–8.19 (2H, m), 8.22 (1H, dd), 8.43 (1H, d), 8.85 (1H, s), 9.23 (1H, d); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 356.37; HPLC <i>t</i><sub>R</sub> = 1.85 min.</div></div><div id="sec9_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 3-(2-Methylpyrimidin-4-yl)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine (<b>32</b>)</h3><div class="NLM_p last">Compound <b>11</b> (0.5 g, 1.4 mmol), acetimidamide hydrochloride (0.67 g, 7 mmol), and potassium 2-methylpropan-2-olate (0.95 g, 8.4 mmol) were suspended in DMA (20 mL) and sealed into a microwave tube. The reaction was heated at 150 °C for 1 h in the microwave reactor and cooled. The reaction mixture was filtered through Celite and concentrated to dryness. The crude product was purified by flash silica chromatography (elution gradient 0–10% 7 M ammonia/methanol in DCM). Pure fractions were evaporated to dryness to afford <b>32</b> (0.22 g, 73%) as a cream solid. <sup>1</sup>H NMR δ 3.29 (3H, s), 7.72 (1H, d), 8.27 (1H, d), 8.40 (1H, dd), 8.54–8.58 (2H, m), 8.83 (1H, d), 12.26 (1H, br s); HRMS: ESI<sup>+</sup><i>m</i>/<i>z</i> calcd, 211.0905; found, 211.09802 (M + H)<sup>+</sup>; HPLC <i>t</i><sub>R</sub> = 1.86 min.</div></div><div id="sec9_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 1-Benzyl-3-(2-methylpyrimidin-4-yl)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine (<b>33</b>)</h3><div class="NLM_p last">Tri-<i>n</i>-butylphosphine (0.24 mL, 0.95 mmol) was added in one portion to compound <b>32</b> (100 mg, 0.5 mmol), benzyl alcohol (0.1 mL, 0.95 mmol), and (<i>E</i>)-diisopropyl diazene-1,2-dicarboxylate (0.19 mL, 0.95 mmol) in degassed THF (4 mL) under nitrogen. The resulting solution was stirred for 18 h and then diluted with methanol, and the crude product was was purified by preparative HPLC using decreasingly polar mixtures of water (containing 1% ammonia) and acetonitrile as eluents. Fractions containing the desired compound were evaporated to dryness to afford <b>33</b> (55 mg, 39%) as a white solid. <sup>1</sup>H NMR δ 2.66 (3H, s), 5.63 (2H, s), 7.24–7.40 (5H, m), 7.69 (1H, d), 8.30 (1H, d), 8.38 (1H, dd), 8.59 (1H, d), 8.75 (1H, s), 8.95 (1H, d); HRMS: ESI<sup>+</sup><i>m</i>/<i>z</i> calcd, 301.1374; found, 301.14432 (M + H)<sup>+</sup>; HPLC <i>t</i><sub>R</sub> = 1.06 min.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00098">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03671" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03671" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Protocols for the enzyme and cell assays, synthetic methods for the remaining examples, crystallographic information, and kinase panel selectivity data for compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00098/suppl_file/jm5b00098_si_001.pdf">jm5b00098_si_001.pdf (433.45 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00098" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31853" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31853" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason G. Kettle</span> - <span class="hlFld-Affiliation affiliation">Oncology
iMed, AstraZeneca, Alderley
Park, Macclesfield, SK10 4TG, United Kingdom</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0862697b676626636d7c7c646d48697b7c7a69726d666d6b69266b6765"><span class="__cf_email__" data-cfemail="0e646f7d616020656b7a7a626b4e6f7d7a7c6f746b606b6d6f206d6163">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Ballard</span> - <span class="hlFld-Affiliation affiliation">Oncology
iMed, AstraZeneca, Alderley
Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Catherine Bardelle</span> - <span class="hlFld-Affiliation affiliation">Oncology
iMed, AstraZeneca, Alderley
Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Cockerill</span> - <span class="hlFld-Affiliation affiliation">Oncology
iMed, AstraZeneca, Alderley
Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicola Colclough</span> - <span class="hlFld-Affiliation affiliation">Oncology
iMed, AstraZeneca, Alderley
Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan E. Critchlow</span> - <span class="hlFld-Affiliation affiliation">Oncology
iMed, AstraZeneca, Alderley
Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Judit Debreczeni</span> - <span class="hlFld-Affiliation affiliation">Oncology
iMed, AstraZeneca, Alderley
Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary Fairley</span> - <span class="hlFld-Affiliation affiliation">Oncology
iMed, AstraZeneca, Alderley
Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shaun Fillery</span> - <span class="hlFld-Affiliation affiliation">Oncology
iMed, AstraZeneca, Alderley
Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark A. Graham</span> - <span class="hlFld-Affiliation affiliation">Oncology
iMed, AstraZeneca, Alderley
Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louise Goodwin</span> - <span class="hlFld-Affiliation affiliation">Oncology
iMed, AstraZeneca, Alderley
Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sylvie Guichard</span> - <span class="hlFld-Affiliation affiliation">Oncology
iMed, AstraZeneca, Alderley
Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Hudson</span> - <span class="hlFld-Affiliation affiliation">Oncology
iMed, AstraZeneca, Alderley
Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard A. Ward</span> - <span class="hlFld-Affiliation affiliation">Oncology
iMed, AstraZeneca, Alderley
Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Whittaker</span> - <span class="hlFld-Affiliation affiliation">Oncology
iMed, AstraZeneca, Alderley
Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27340" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27340" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 22 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lee, K.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, E.</span><span> </span><span class="NLM_article-title">Mirk protein kinase is a mitogen-activated protein kinase substrate that mediates survival of colon cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">3631</span><span class="NLM_x">–</span> <span class="NLM_lpage">3637</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=3631-3637&author=K.-M.+Leeauthor=X.+Dengauthor=E.+Friedman&title=Mirk+protein+kinase+is+a+mitogen-activated+protein+kinase+substrate+that+mediates+survival+of+colon+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.-M.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DFriedman%26aufirst%3DE.%26atitle%3DMirk%2520protein%2520kinase%2520is%2520a%2520mitogen-activated%2520protein%2520kinase%2520substrate%2520that%2520mediates%2520survival%2520of%2520colon%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D3631%26epage%3D3637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mercer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewton, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazur, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, E.</span><span> </span><span class="NLM_article-title">Myrk/Dyrk1B mediates survival during the differentiation of C2C12 myoblasts</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">25788</span><span class="NLM_x">–</span> <span class="NLM_lpage">25801</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=25788-25801&author=S.+E.+Mercerauthor=D.+Z.+Ewtonauthor=X.+Dengauthor=S.+Limauthor=T.+R.+Mazurauthor=E.+Friedman&title=Myrk%2FDyrk1B+mediates+survival+during+the+differentiation+of+C2C12+myoblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMercer%26aufirst%3DS.%2BE.%26aulast%3DEwton%26aufirst%3DD.%2BZ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DLim%26aufirst%3DS.%26aulast%3DMazur%26aufirst%3DT.%2BR.%26aulast%3DFriedman%26aufirst%3DE.%26atitle%3DMyrk%252FDyrk1B%2520mediates%2520survival%2520during%2520the%2520differentiation%2520of%2520C2C12%2520myoblasts%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D25788%26epage%3D25801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Becker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joost, H. G.</span><span> </span><span class="NLM_article-title">Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity</span> <span class="citation_source-journal">Prog. Nucleic Acid Res. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=10.1016%2FS0079-6603%2808%2960503-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=9932450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=1%3ACAS%3A528%3ADyaK1MXnsFKnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1999&pages=1-17&author=W.+Beckerauthor=H.+G.+Joost&title=Structural+and+functional+characteristics+of+Dyrk%2C+a+novel+subfamily+of+protein+kinases+with+dual+specificity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity</span></div><div class="casAuthors">Becker, Walter; Joost, Hans-Georg</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Nucleic Acid Research and Molecular Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-17</span>CODEN:
                <span class="NLM_cas:coden">PNMBAF</span>;
        ISSN:<span class="NLM_cas:issn">0079-6603</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review with 40 refs.  Dyrk-related kinases represent a novel subfamily of protein kinases with unique structural and enzymic features.  Its members have been identified in distantly related organisms.  The yeast kinase, Yak1, has been characterized as a neg. regulator of growth.  Mnb from Drosophila is encoded by the minibrain gene, whose mutation results in specific defects in neurogenesis.  Its mammalian homolog, Dyrk1A, is activated by tyrosine phosphorylation in the activation loop between subdomains VII and VIII of the catalytic domain.  The human gene for Dyrk1A is located in the "Down syndrome crit. region" of chromosome 21 and is therefore a candidate gene for mental retardation in Down syndrome.  More recently, six addnl. mammalian Dyrk-related kinases have been identified (Dyrk1B, Dyrk1C, Dyrk2, Dyrk3, Dyrk4A, and Dyrk4B).  All members of the Dyrk family contain in the activation loop the tyrosines that are essential for the full activity of Dyrk1A.  Outside their catalytic domains, Dyrk kinases exhibit little sequence similarity except for a small segment immediately preceding the catalytic domain (DH-box, Dyrk homol. box).  An unusual enzymic property of Dyrk-related kinases is their ability to catalyze tyrosine-directed autophosphorylation as well as phosphorylation of serine/threonine residues in exogenous substrates.  The exact cellular function of the Dyrk kinases is yet unknown.  However, it appears reasonable to assume that they are involved in the regulation of cellular growth and/or development.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNSdgeZiMKybVg90H21EOLACvtfcHk0ljy_cGa8n6DeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnsFKnsQ%253D%253D&md5=1e7059810f856d0c38018ca285fc7e60</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0079-6603%2808%2960503-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6603%252808%252960503-6%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DJoost%26aufirst%3DH.%2BG.%26atitle%3DStructural%2520and%2520functional%2520characteristics%2520of%2520Dyrk%252C%2520a%2520novel%2520subfamily%2520of%2520protein%2520kinases%2520with%2520dual%2520specificity%26jtitle%3DProg.%2520Nucleic%2520Acid%2520Res.%2520Mol.%2520Biol.%26date%3D1999%26volume%3D62%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Friedman, E.</span><span> </span><span class="NLM_article-title">Mirk/Dyrk1B in cancer</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">274</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2007&pages=274-279&author=E.+Friedman&title=Mirk%2FDyrk1B+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFriedman%26aufirst%3DE.%26atitle%3DMirk%252FDyrk1B%2520in%2520cancer%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2007%26volume%3D102%26spage%3D274%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, E. A.</span><span> </span><span class="NLM_article-title">Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">2258</span><span class="NLM_x">–</span> <span class="NLM_lpage">2269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=10.1002%2Fijc.27917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=23114871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12rsbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2013&pages=2258-2269&author=J.+Huauthor=H.+Dengauthor=E.+A.+Friedman&title=Ovarian+cancer+cells%2C+not+normal+cells%2C+are+damaged+by+Mirk%2FDyrk1B+kinase+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition</span></div><div class="casAuthors">Hu, Jing; Deng, Holly; Friedman, Eileen A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2258-2269</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Prior studies had shown that the Mirk/dyrk1B gene is amplified/upregulated in about 75% of ovarian cancers, that protein levels of this kinase are elevated in quiescent G0 cells and that Mirk maintains tumor cells in quiescence by initiating rapid degrdn. of cyclin D isoforms and by phosphorylation of a member of the DREAM complex.  Depletion of Mirk/dyrk1B led to increased cyclin D levels, an elevated reactive oxygen species (ROS) content and loss of viability.  However, many normal cells in vivo are quiescent, and therefore, targeting a kinase found in quiescent cells might be problematic.  In our study, Mirk kinase activity was found to be higher in ovarian cancer cells than in normal cells.  Pharmacol. inhibition of Mirk/dyrk1B kinase increased cyclin D levels both in quiescent normal diploid cells and in quiescent CDKN2A-neg. ovarian cancer cells, but led to more active CDK4/cyclin D complexes in quiescent ovarian cancer cells, allowing them to escape G0/G1 quiescence, enter cycle with high ROS levels and undergo apoptosis.  The ROS scavenger N-acetyl cysteine reduced both the amt. of cleaved poly(ADP-ribose) polymerase (PARP) and the extent of cancer cell loss.  In contrast, normal cells were spared because of their expression of cyclin directed kinase (CDK) inhibitors that blocked unregulated cycling.  Quiescent early passage normal ovarian epithelial cells and two strains of quiescent normal diploid fibroblasts remained viable after the inhibition of Mirk/dyrk1B kinase, and the few cells that left G0/G1 quiescence were accumulated in G2+M.  Thus, inhibition of Mirk kinase targeted quiescent ovarian cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWFUPgfQBJiLVg90H21EOLACvtfcHk0lic-KJAw9WU0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12rsbfF&md5=e0cf1c67ac4a66f2e12055bb0df0df0b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fijc.27917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.27917%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DH.%26aulast%3DFriedman%26aufirst%3DE.%2BA.%26atitle%3DOvarian%2520cancer%2520cells%252C%2520not%2520normal%2520cells%252C%2520are%2520damaged%2520by%2520Mirk%252FDyrk1B%2520kinase%2520inhibition%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2013%26volume%3D132%26spage%3D2258%26epage%3D2269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornicek, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, Z.</span><span> </span><span class="NLM_article-title">The kinase Mirk is a potential therapeutic target in osteosarcoma</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">558</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=552-558&author=C.+Yangauthor=D.+Jiauthor=E.+J.+Weinsteinauthor=E.+Choyauthor=F.+J.+Hornicekauthor=K.+B.+Woodauthor=X.+Liuauthor=H.+Mankinauthor=Z.+Duan&title=The+kinase+Mirk+is+a+potential+therapeutic+target+in+osteosarcoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%26aulast%3DJi%26aufirst%3DD.%26aulast%3DWeinstein%26aufirst%3DE.%2BJ.%26aulast%3DChoy%26aufirst%3DE.%26aulast%3DHornicek%26aufirst%3DF.%2BJ.%26aulast%3DWood%26aufirst%3DK.%2BB.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMankin%26aufirst%3DH.%26aulast%3DDuan%26aufirst%3DZ.%26atitle%3DThe%2520kinase%2520Mirk%2520is%2520a%2520potential%2520therapeutic%2520target%2520in%2520osteosarcoma%26jtitle%3DCarcinogenesis%26date%3D2010%26volume%3D31%26spage%3D552%26epage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Keramati, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fathzadeh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Go, G.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faramarzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mane, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasaei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarajzadeh-Fard, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kidd, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babaee Bigi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malekzadeh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosseinian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babaei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lifton, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mani, A.</span><span> </span><span class="NLM_article-title">A form of the metabolic syndrome associated with mutations in DYRK1B</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">1909</span><span class="NLM_x">–</span> <span class="NLM_lpage">1919</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=10.1056%2FNEJMoa1301824" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=24827035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGksbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=1909-1919&author=A.+R.+Keramatiauthor=M.+Fathzadehauthor=G.-W.+Goauthor=R.+Singhauthor=M.+Choiauthor=S.+Faramarziauthor=S.+Maneauthor=M.+Kasaeiauthor=K.+Sarajzadeh-Fardauthor=J.+Hwaauthor=K.+K.+Kiddauthor=M.+A.+Babaee+Bigiauthor=R.+Malekzadehauthor=A.+Hosseinianauthor=M.+Babaeiauthor=R.+P.+Liftonauthor=A.+Mani&title=A+form+of+the+metabolic+syndrome+associated+with+mutations+in+DYRK1B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A form of the metabolic syndrome associated with mutations in DYRK1B</span></div><div class="casAuthors">Keramati, Ali R.; Fathzadeh, Mohsen; Go, Gwang-Woong; Singh, Rajvir; Choi, Murim; Faramarzi, Saeed; Mane, Shrikant; Kasaei, Mohammad; Sarajzadeh-Fard, Kazem; Hwa, John; Kidd, Kenneth K.; Bigi, Mohammad A. Babaee; Malekzadeh, Reza; Hosseinian, Adallat; Babaei, Masoud; Lifton, Richard P.; Mani, Arya</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1909-1919, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Genetic anal. has been successful in identifying causative mutations for individual cardiovascular risk factors.  Success has been more limited in mapping susceptibility genes for clusters of cardiovascular risk traits, such as those in the metabolic syndrome.  Methods: We identified three large families with coinheritance of early-onset coronary artery disease, central obesity, hypertension, and diabetes.  We used linkage anal. and whole-exome sequencing to identify the disease-causing gene.  Results: A founder mutation was identified in DYRK1B, substituting cysteine for arginine at position 102 in the highly conserved kinase-like domain.  The mutation precisely cosegregated with the clin. syndrome in all the affected family members and was absent in unaffected family members and unrelated controls.  Functional characterization of the disease gene revealed that nonmutant protein encoded by DYRK1B inhibits the SHH (sonic hedgehog) and Wnt signaling pathways and consequently enhances adipogenesis.  Furthermore, DYRK1B promoted the expression of the key gluconeogenic enzyme glucose-6-phosphatase.  The R102C allele showed gain-of-function activities by potentiating these effects.  A second mutation, substituting proline for histidine 90, was found to cosegregate with a similar clin. syndrome in an ethnically distinct family.  Conclusions: These findings indicate a role for DYRK1B in adipogenesis and glucose homeostasis and assoc. its altered function with an inherited form of the metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ4PIrgg04UbVg90H21EOLACvtfcHk0lic-KJAw9WU0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGksbnO&md5=a964b3a4c701294e46ddfcdf1de76b14</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1301824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1301824%26sid%3Dliteratum%253Aachs%26aulast%3DKeramati%26aufirst%3DA.%2BR.%26aulast%3DFathzadeh%26aufirst%3DM.%26aulast%3DGo%26aufirst%3DG.-W.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DChoi%26aufirst%3DM.%26aulast%3DFaramarzi%26aufirst%3DS.%26aulast%3DMane%26aufirst%3DS.%26aulast%3DKasaei%26aufirst%3DM.%26aulast%3DSarajzadeh-Fard%26aufirst%3DK.%26aulast%3DHwa%26aufirst%3DJ.%26aulast%3DKidd%26aufirst%3DK.%2BK.%26aulast%3DBabaee%2BBigi%26aufirst%3DM.%2BA.%26aulast%3DMalekzadeh%26aufirst%3DR.%26aulast%3DHosseinian%26aufirst%3DA.%26aulast%3DBabaei%26aufirst%3DM.%26aulast%3DLifton%26aufirst%3DR.%2BP.%26aulast%3DMani%26aufirst%3DA.%26atitle%3DA%2520form%2520of%2520the%2520metabolic%2520syndrome%2520associated%2520with%2520mutations%2520in%2520DYRK1B%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26spage%3D1909%26epage%3D1919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Loidreau, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubouilh-Benard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nourrisson, M.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duflos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loaëc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of <i>N</i>-aryl-7-methoxybenzo[<i>b</i>]furo[3,2-<i>d</i>]pyrimidin-4-amines and their <i>N</i>-arylbenzo[<i>b</i>]thieno[3,2-<i>d</i>]pyrimidin-4-amine analogues as dual inhibitors of CLK1 and DYRK1A kinases</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2013&pages=283-295&author=Y.+Loidreauauthor=P.+Marchandauthor=C.+Dubouilh-Benardauthor=M.-R.+Nourrissonauthor=M.+Duflosauthor=N.+Loa%C3%ABcauthor=L.+Meijerauthor=T.+Besson&title=Synthesis+and+biological+evaluation+of+N-aryl-7-methoxybenzo%5Bb%5Dfuro%5B3%2C2-d%5Dpyrimidin-4-amines+and+their+N-arylbenzo%5Bb%5Dthieno%5B3%2C2-d%5Dpyrimidin-4-amine+analogues+as+dual+inhibitors+of+CLK1+and+DYRK1A+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLoidreau%26aufirst%3DY.%26aulast%3DMarchand%26aufirst%3DP.%26aulast%3DDubouilh-Benard%26aufirst%3DC.%26aulast%3DNourrisson%26aufirst%3DM.-R.%26aulast%3DDuflos%26aufirst%3DM.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520N-aryl-7-methoxybenzo%255Bb%255Dfuro%255B3%252C2-d%255Dpyrimidin-4-amines%2520and%2520their%2520N-arylbenzo%255Bb%255Dthieno%255B3%252C2-d%255Dpyrimidin-4-amine%2520analogues%2520as%2520dual%2520inhibitors%2520of%2520CLK1%2520and%2520DYRK1A%2520kinases%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D59%26spage%3D283%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span> </span><span class="NLM_article-title">Discovery of potent small molecule inhibitors of DYRK1A by structure-based virtual screening and bioassay</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=168-171&author=D.+Wangauthor=F.+Wangauthor=Y.+Tanauthor=L.+Dongauthor=L.+Chenauthor=W.+Zhuauthor=H.+Wang&title=Discovery+of+potent+small+molecule+inhibitors+of+DYRK1A+by+structure-based+virtual+screening+and+bioassay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DTan%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520potent%2520small%2520molecule%2520inhibitors%2520of%2520DYRK1A%2520by%2520structure-based%2520virtual%2520screening%2520and%2520bioassay%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D168%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Altafaj, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierssen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baamonde, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oset, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalex, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillat, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estivill, X.</span><span> </span><span class="NLM_article-title">Neurodevelopmental delay, motor abnormalities and cognitive defects in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down’s syndrome</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1915</span><span class="NLM_x">–</span> <span class="NLM_lpage">1923</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=10.1093%2Fhmg%2F10.18.1915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=11555628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntlSgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2001&pages=1915-1923&author=X.+Altafajauthor=M.+Dierssenauthor=C.+Baamondeauthor=E.+Martiauthor=J.+Visaauthor=J.+Guimeraauthor=M.+Osetauthor=J.+Gonzalexauthor=J.+Florezauthor=C.+Fillatauthor=X.+Estivill&title=Neurodevelopmental+delay%2C+motor+abnormalities+and+cognitive+defects+in+transgenic+mice+overexpressing+Dyrk1A+%28minibrain%29%2C+a+murine+model+of+Down%E2%80%99s+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome</span></div><div class="casAuthors">Altafaj, Xavier; Dierssen, Mara; Baamonde, Carmela; Marti, Eulalia; Visa, Joana; Guimera, Jordi; Oset, Marta; Gonzalez, Juan Ramon; Florez, Jesus; Fillat, Cristina; Estivill, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1915-1923</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Down's syndrome (DS) is a major cause of mental retardation, hypotonia and delayed development.  Murine models of DS carrying large murine or human genomic fragments show motor alterations and memory deficits.  The specific genes responsible for these phenotypic alterations have not yet been defined.  DYRK1A, the human homolog of the Drosophila minibrain gene, maps to the DS crit. region of human chromosome 21 and is overexpressed in DS fetal brain.  DYRK1A encodes a serine-threonine kinase, probably involved in neuroblast proliferation.  Mutant Drosophila minibrain flies have a redn. in both optic lobes and central brain, showing learning deficits and hypoactivity.  We have generated transgenic mice (TgDyrk1A) overexpressing the full-length cDNA of Dyrk1A.  TgDyrk1A mice exhibit delayed craniocaudal maturation with functional consequences in neuromotor development.  TgDyrk1A mice also show altered motor skill acquisition and hyperactivity, which is maintained to adulthood.  In the Morris water maze, TgDyrk1A mice show a significant impairment in spatial learning and cognitive flexibility, indicative of hippocampal and prefrontal cortex dysfunction.  In the more complex repeated reversal learning paradigm, this defect turned out to be specifically related to ref. memory, whereas working memory was almost unimpaired.  These alterations are comparable with those found in the partial trisomy chromosome 16 murine models of DS and suggest a causative role of DYRK1A in mental retardation and in motor anomalies of DS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwXDiQutGJ07Vg90H21EOLACvtfcHk0lj43KMjVL7VUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntlSgsb0%253D&md5=f31c3a38ca72e9d5709a489f34732b6a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F10.18.1915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F10.18.1915%26sid%3Dliteratum%253Aachs%26aulast%3DAltafaj%26aufirst%3DX.%26aulast%3DDierssen%26aufirst%3DM.%26aulast%3DBaamonde%26aufirst%3DC.%26aulast%3DMarti%26aufirst%3DE.%26aulast%3DVisa%26aufirst%3DJ.%26aulast%3DGuimera%26aufirst%3DJ.%26aulast%3DOset%26aufirst%3DM.%26aulast%3DGonzalex%26aufirst%3DJ.%26aulast%3DFlorez%26aufirst%3DJ.%26aulast%3DFillat%26aufirst%3DC.%26aulast%3DEstivill%26aufirst%3DX.%26atitle%3DNeurodevelopmental%2520delay%252C%2520motor%2520abnormalities%2520and%2520cognitive%2520defects%2520in%2520transgenic%2520mice%2520overexpressing%2520Dyrk1A%2520%2528minibrain%2529%252C%2520a%2520murine%2520model%2520of%2520Down%25E2%2580%2599s%2520syndrome%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2001%26volume%3D10%26spage%3D1915%26epage%3D1923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Metro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minotti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crino, L.</span><span> </span><span class="NLM_article-title">Selumetinib: a promising pharmacologic approach for KRAS-mutant advanced non-small-cell lung cancer</span> <span class="citation_source-journal">Future Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=10.2217%2Ffon.12.198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=23414467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1Chsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=167-177&author=G.+Metroauthor=R.+Chiariauthor=A.+Baldiauthor=V.+De+Angelisauthor=V.+Minottiauthor=L.+Crino&title=Selumetinib%3A+a+promising+pharmacologic+approach+for+KRAS-mutant+advanced+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Selumetinib: a promising pharmacologic approach for KRAS-mutant advanced non-small-cell lung cancer</span></div><div class="casAuthors">Metro, Giulio; Chiari, Rita; Baldi, Alice; De Angelis, Verena; Minotti, Vincenzo; Crino, Lucio</div><div class="citationInfo"><span class="NLM_cas:title">Future Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-177</span>CODEN:
                <span class="NLM_cas:coden">FOUNBN</span>;
        ISSN:<span class="NLM_cas:issn">1479-6694</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Selumetinib is a potent and selective inhibitor of MEK1 and 2 that is currently being clin. developed for the treatment of several human malignancies.  Initially administered as free-base suspension, a more convenient Hyd-sulfate capsule formulation has recently been developed.  Phase I studies revealed that acneiform dermatitis was the dose-limiting toxicity of both the free-base and capsule formulation given two-times a day at the max. tolerated doses of 100 and 75 mg, resp., with the capsule formulation resulting into a significantly higher drug bioavailability.  Importantly, as a MEK inhibitor, selumetinib could be particularly effective in tumors with a hyperactivated Ras/Raf/MEK/ERK pathway, which might be the case of KRAS-mutant non-small-cell lung cancers (NSCLCs).  Accordingly, a recent randomized Phase II study evaluating docetaxel plus selumetinib or placebo in KRAS-mutant pretreated advanced NSCLC patients has demonstrated a significant improvement in terms of response rate, progression-free survival and patient-reported outcomes in favor of the combination arm.  These pos. results support further clin. evaluation of selumetinib in NSCLC, and confirmatory ongoing and future trials will assess its role according to KRAS-mutation status and in combination regimens with other targeted agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxRYBFujBPTbVg90H21EOLACvtfcHk0lj43KMjVL7VUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1Chsrw%253D&md5=c383f88192524739b6d57f99fa1bc173</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2217%2Ffon.12.198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffon.12.198%26sid%3Dliteratum%253Aachs%26aulast%3DMetro%26aufirst%3DG.%26aulast%3DChiari%26aufirst%3DR.%26aulast%3DBaldi%26aufirst%3DA.%26aulast%3DDe%2BAngelis%26aufirst%3DV.%26aulast%3DMinotti%26aufirst%3DV.%26aulast%3DCrino%26aufirst%3DL.%26atitle%3DSelumetinib%253A%2520a%2520promising%2520pharmacologic%2520approach%2520for%2520KRAS-mutant%2520advanced%2520non-small-cell%2520lung%2520cancer%26jtitle%3DFuture%2520Oncol.%26date%3D2013%26volume%3D9%26spage%3D167%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Cohen, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aamdal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyakas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavallin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Learoyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurzrock, R.</span><span> </span><span class="NLM_article-title">A phase I dose-finding, safety and tolerability study of AZD8330 in patients with advanced malignancies</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1521</span><span class="NLM_x">–</span> <span class="NLM_lpage">1529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=1521-1529&author=R.+B.+Cohenauthor=S.+Aamdalauthor=M.+Nyakasauthor=M.+Cavallinauthor=D.+Greenauthor=M.+Learoydauthor=I.+Smithauthor=R.+Kurzrock&title=A+phase+I+dose-finding%2C+safety+and+tolerability+study+of+AZD8330+in+patients+with+advanced+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DR.%2BB.%26aulast%3DAamdal%26aufirst%3DS.%26aulast%3DNyakas%26aufirst%3DM.%26aulast%3DCavallin%26aufirst%3DM.%26aulast%3DGreen%26aufirst%3DD.%26aulast%3DLearoyd%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DI.%26aulast%3DKurzrock%26aufirst%3DR.%26atitle%3DA%2520phase%2520I%2520dose-finding%252C%2520safety%2520and%2520tolerability%2520study%2520of%2520AZD8330%2520in%2520patients%2520with%2520advanced%2520malignancies%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2013%26volume%3D49%26spage%3D1521%26epage%3D1529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Anderson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominique, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luk, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polonskaia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Railkar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenchik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wovkulich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span> </span><span class="NLM_article-title">Pyrido[2,3-d]pyrimidines: discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6610</span><span class="NLM_x">–</span> <span class="NLM_lpage">6615</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6610-6615&author=K.+Andersonauthor=Y.+Chenauthor=Z.+Chenauthor=R.+Dominiqueauthor=K.+Glennauthor=Y.+Heauthor=C.+Jansonauthor=K.-C.+Lukauthor=C.+Lukacsauthor=A.+Polonskaiaauthor=Q.+Qiaoauthor=A.+Railkarauthor=P.+Rossmanauthor=H.+Sunauthor=Q.+Xiangauthor=M.+Vilenchikauthor=P.+Wovkulichauthor=X.+Zhang&title=Pyrido%5B2%2C3-d%5Dpyrimidines%3A+discovery+and+preliminary+SAR+of+a+novel+series+of+DYRK1B+and+DYRK1A+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDominique%26aufirst%3DR.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DJanson%26aufirst%3DC.%26aulast%3DLuk%26aufirst%3DK.-C.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DPolonskaia%26aufirst%3DA.%26aulast%3DQiao%26aufirst%3DQ.%26aulast%3DRailkar%26aufirst%3DA.%26aulast%3DRossman%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DXiang%26aufirst%3DQ.%26aulast%3DVilenchik%26aufirst%3DM.%26aulast%3DWovkulich%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DPyrido%255B2%252C3-d%255Dpyrimidines%253A%2520discovery%2520and%2520preliminary%2520SAR%2520of%2520a%2520novel%2520series%2520of%2520DYRK1B%2520and%2520DYRK1A%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6610%26epage%3D6615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Coombs, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanega, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auld, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerritz, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenen, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aube, J.</span><span> </span><span class="NLM_article-title">Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3654</span><span class="NLM_x">–</span> <span class="NLM_lpage">3661</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3654-3661&author=T.+C.+Coombsauthor=C.+Tanegaauthor=M.+Shenauthor=J.+L.+Wangauthor=D.+S.+Auldauthor=S.+W.+Gerritzauthor=F.+J.+Schoenenauthor=C.+J.+Thomasauthor=J.+Aube&title=Small-molecule+pyrimidine+inhibitors+of+the+cdc2-like+%28Clk%29+and+dual+specificity+tyrosine+phosphorylation-regulated+%28Dyrk%29+kinases%3A+development+of+chemical+probe+ML315"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoombs%26aufirst%3DT.%2BC.%26aulast%3DTanega%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%2BL.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DGerritz%26aufirst%3DS.%2BW.%26aulast%3DSchoenen%26aufirst%3DF.%2BJ.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DAube%26aufirst%3DJ.%26atitle%3DSmall-molecule%2520pyrimidine%2520inhibitors%2520of%2520the%2520cdc2-like%2520%2528Clk%2529%2520and%2520dual%2520specificity%2520tyrosine%2520phosphorylation-regulated%2520%2528Dyrk%2529%2520kinases%253A%2520development%2520of%2520chemical%2520probe%2520ML315%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3654%26epage%3D3661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rosse, G.</span><span> </span><span class="NLM_article-title">Tricyclic pyrimidines as inhibitors of DYRK1A/DYRK1B as potential treatment for Down’s syndrome or Alzheimer’s disease</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">502</span><span class="NLM_x">–</span> <span class="NLM_lpage">503</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml400137s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=502-503&author=G.+Rosse&title=Tricyclic+pyrimidines+as+inhibitors+of+DYRK1A%2FDYRK1B+as+potential+treatment+for+Down%E2%80%99s+syndrome+or+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1021%2Fml400137s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400137s%26sid%3Dliteratum%253Aachs%26aulast%3DRosse%26aufirst%3DG.%26atitle%3DTricyclic%2520pyrimidines%2520as%2520inhibitors%2520of%2520DYRK1A%252FDYRK1B%2520as%2520potential%2520treatment%2520for%2520Down%25E2%2580%2599s%2520syndrome%2520or%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D502%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Schmitt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kail, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Empting, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of a library of lead-like 2,4-bisheterocyclic substituted thiophenes as selective Dyrk/Clk inhibitors</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e87851</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e87851&author=C.+Schmittauthor=D.+Kailauthor=M.+Marianoauthor=M.+Emptingauthor=N.+Weberauthor=T.+Paulauthor=R.+W.+Hartmannauthor=M.+Engel&title=Design+and+synthesis+of+a+library+of+lead-like+2%2C4-bisheterocyclic+substituted+thiophenes+as+selective+Dyrk%2FClk+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DC.%26aulast%3DKail%26aufirst%3DD.%26aulast%3DMariano%26aufirst%3DM.%26aulast%3DEmpting%26aufirst%3DM.%26aulast%3DWeber%26aufirst%3DN.%26aulast%3DPaul%26aufirst%3DT.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DEngel%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520library%2520of%2520lead-like%25202%252C4-bisheterocyclic%2520substituted%2520thiophenes%2520as%2520selective%2520Dyrk%252FClk%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De87851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Göckler, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jofre, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soppa, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejedor, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, W.</span><span> </span><span class="NLM_article-title">Harmine specifically inhibits protein kinase Dyrk1A and interferes with neurite formation</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">6324</span><span class="NLM_x">–</span> <span class="NLM_lpage">6337</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=6324-6337&author=N.+G%C3%B6cklerauthor=G.+Jofreauthor=C.+Papadopoulosauthor=U.+Soppaauthor=F.+J.+Tejedorauthor=W.+Becker&title=Harmine+specifically+inhibits+protein+kinase+Dyrk1A+and+interferes+with+neurite+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6ckler%26aufirst%3DN.%26aulast%3DJofre%26aufirst%3DG.%26aulast%3DPapadopoulos%26aufirst%3DC.%26aulast%3DSoppa%26aufirst%3DU.%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DHarmine%2520specifically%2520inhibits%2520protein%2520kinase%2520Dyrk1A%2520and%2520interferes%2520with%2520neurite%2520formation%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D6324%26epage%3D6337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shpiro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastie, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevernic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The selectivity of protein kinase inhibitors: a further update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&author=J.+Bainauthor=L.+Palterauthor=M.+Elliottauthor=N.+Shpiroauthor=C.+J.+Hastieauthor=H.+McLauchlanauthor=I.+Klevernicauthor=J.+S.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+selectivity+of+protein+kinase+inhibitors%3A+a+further+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0lgPnshQwMZ6zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPalter%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%253A%2520a%2520further%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26spage%3D297%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesuma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, R. Z.</span><span> </span><span class="NLM_article-title">Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=10.1016%2Fj.bbrc.2004.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=15047157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVKmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2004&pages=128-132&author=Y.+Songauthor=D.+Kesumaauthor=J.+Wangauthor=Y.+Dengauthor=J.+Duanauthor=J.+H.+Wangauthor=R.+Z.+Qi&title=Specific+inhibition+of+cyclin-dependent+kinases+and+cell+proliferation+by+harmine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine</span></div><div class="casAuthors">Song, Yongcheng; Kesuma, Djohan; Wang, Jian; Deng, Yu; Duan, Jinao; Wang, Jerry H.; Qi, Robert Z.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-132</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">As key regulators of the cell proliferation cycle, cyclin-dependent kinases (CDKs) are attractive targets for the development of anti-tumor drugs.  In the present study, harmine was identified from a collection of herbal compds. to be a specific inhibitor of Cdk1/cyclin B, Cdk2/cyclin A, and Cdk5/p25 with IC50 values at low micromoles.  It displayed little effect on other serine/threonine and tyrosine kinases tested.  The CDK inhibition by harmine is competitive with ATP-Mg2+, suggesting that it binds to the ATP-Mg2+-binding pocket of CDKs.  In cytotoxicity assays, harmine exhibited a strong inhibitory effect on the growth and proliferation of carcinoma cells whereas it had no significant effect on quiescent fibroblasts.  Further, harmine was found to block DNA replication in the carcinoma cells.  Taken together, harmine is a selective inhibitor of CDKs and cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9drfO7NpUHrVg90H21EOLACvtfcHk0lgPnshQwMZ6zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVKmt74%253D&md5=1a88a183ab790612a3e4c3d7c147eca6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2004.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2004.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DKesuma%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DQi%26aufirst%3DR.%2BZ.%26atitle%3DSpecific%2520inhibition%2520of%2520cyclin-dependent%2520kinases%2520and%2520cell%2520proliferation%2520by%2520harmine%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2004%26volume%3D317%26spage%3D128%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Waki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damoiseaux, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilpitz, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontonoz, P.</span><span> </span><span class="NLM_article-title">The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARgamma expression</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=10.1016%2Fj.cmet.2007.03.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=17488638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt1Wqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=357-370&author=H.+Wakiauthor=K.+W.+Parkauthor=N.+Mitroauthor=L.+Peiauthor=R.+Damoiseauxauthor=D.+C.+Wilpitzauthor=K.+Reueauthor=E.+Saezauthor=P.+Tontonoz&title=The+small+molecule+harmine+is+an+antidiabetic+cell-type-specific+regulator+of+PPARgamma+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARγ expression</span></div><div class="casAuthors">Waki, Hironori; Park, Kye Won; Mitro, Nico; Pei, Liming; Damoiseaux, Robert; Wilpitz, Damien C.; Reue, Karen; Saez, Enrique; Tontonoz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">357-370</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">PPARγ is the master regulator of adipogenesis and the mol. target of the thiazolidinedione antidiabetic drugs.  By screening for compds. that promote adipogenesis, we identified a small mol. that targets the PPARγ pathway by a distinct mechanism.  This mol., harmine, is not a ligand for the receptor; rather, it acts as a cell-type-specific regulator of PPARγ expression.  Administration of harmine to diabetic mice mimics the effects of PPARγ ligands on adipocyte gene expression and insulin sensitivity.  Unlike thiazolidinediones, however, harmine does not cause significant wt. gain or hepatic lipid accumulation.  Mol. studies indicate that harmine controls PPARγ expression through inhibition of the Wnt signaling pathway.  This work validates phenotypic screening of adipocytes as a promising strategy for the identification of bioactive small mols. and suggests that regulators of PPARγ expression may represent a complementary approach to PPARγ ligands in the treatment of insulin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Im5tRGS5LbVg90H21EOLACvtfcHk0lgPnshQwMZ6zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt1Wqu7s%253D&md5=a2b9ff7b3eb65a8eef51d848d185b386</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2007.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2007.03.010%26sid%3Dliteratum%253Aachs%26aulast%3DWaki%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DK.%2BW.%26aulast%3DMitro%26aufirst%3DN.%26aulast%3DPei%26aufirst%3DL.%26aulast%3DDamoiseaux%26aufirst%3DR.%26aulast%3DWilpitz%26aufirst%3DD.%2BC.%26aulast%3DReue%26aufirst%3DK.%26aulast%3DSaez%26aufirst%3DE.%26aulast%3DTontonoz%26aufirst%3DP.%26atitle%3DThe%2520small%2520molecule%2520harmine%2520is%2520an%2520antidiabetic%2520cell-type-specific%2520regulator%2520of%2520PPARgamma%2520expression%26jtitle%3DCell%2520Metab.%26date%3D2007%26volume%3D5%26spage%3D357%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sablin, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsay, R. R.</span><span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase A by beta-carboline derivatives</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">337</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=1997&pages=137-142&author=H.+Kimauthor=S.+O.+Sablinauthor=R.+R.+Ramsay&title=Inhibition+of+monoamine+oxidase+A+by+beta-carboline+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DSablin%26aufirst%3DS.%2BO.%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520A%2520by%2520beta-carboline%2520derivatives%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1997%26volume%3D337%26spage%3D137%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ducray, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissink, J. W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, K.</span><span> </span><span class="NLM_article-title">Discovery of novel imidazo[1,2-<i>a</i>]pyridines as inhibitors of the insulin-like growth factor-1 receptor tyrosine kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4698</span><span class="NLM_x">–</span> <span class="NLM_lpage">4701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4698-4701&author=R.+Ducrayauthor=I.+Simpsonauthor=F.+H.+Jungauthor=J.+W.+M.+Nissinkauthor=P.+W.+Kennyauthor=M.+Fitzekauthor=G.+E.+Walkerauthor=L.+T.+Wardauthor=K.+Hudson&title=Discovery+of+novel+imidazo%5B1%2C2-a%5Dpyridines+as+inhibitors+of+the+insulin-like+growth+factor-1+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDucray%26aufirst%3DR.%26aulast%3DSimpson%26aufirst%3DI.%26aulast%3DJung%26aufirst%3DF.%2BH.%26aulast%3DNissink%26aufirst%3DJ.%2BW.%2BM.%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DFitzek%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DG.%2BE.%26aulast%3DWard%26aufirst%3DL.%2BT.%26aulast%3DHudson%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520novel%2520imidazo%255B1%252C2-a%255Dpyridines%2520as%2520inhibitors%2520of%2520the%2520insulin-like%2520growth%2520factor-1%2520receptor%2520tyrosine%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4698%26epage%3D4701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Kothe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohls, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennie, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feru, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.-H.</span><span> </span><span class="NLM_article-title">Selectivity-determining residues in Plk1</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=10.1111%2Fj.1747-0285.2007.00594.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=18005335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGhsbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=540-546&author=M.+Kotheauthor=D.+Kohlsauthor=S.+Lowauthor=R.+Coliauthor=G.+R.+Rennieauthor=F.+Feruauthor=C.+Kuhnauthor=Y.-H.+Ding&title=Selectivity-determining+residues+in+Plk1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity-determining residues in Plk1</span></div><div class="casAuthors">Kothe, Michael; Kohls, Darcy; Low, Simon; Coli, Rocco; Rennie, Glen R.; Feru, Frederic; Kuhn, Cyrille; Ding, Yuan-Hua</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">540-546</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Polo-like kinase 1 is an important regulator of cell cycle progression whose over-expression is often assocd. with oncogenesis.  Polo-like kinase 1 hence represents an attractive target for cancer intervention.  BI 2536 (Boehringer Ingelheim, Ingelheim, Germany), a Polo-like kinase 1 inhibitor currently in clin. trials, exhibits nanomolar potency against Polo-like kinase isoforms and high selectivity against other kinases.  The authors have previously published the crystal structures of the Polo-like kinase 1 domain in complex with AMPPNP and an Aurora A inhibitor.  In this work, the authors present the cocrystal structure of Polo-like kinase 1 with BI 2536.  The structure, in combination with selectivity data for BI 2536 and related compds., illustrates important features for potency and selectivity.  In particular, the authors show that the methoxy group of BI 2536 is an important specificity determinant against non-Polo-like kinases by taking advantage of a small pocket generated by Leu 132 in the hinge region of Polo-like kinase 1.  The work presented here provides a framework for structure-based drug design of Polo-like kinase 1-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjA3mwWD7K0bVg90H21EOLACvtfcHk0lhihQZUYIaXxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGhsbrJ&md5=0f976bb98fe7d0413e8d2314abc68e2b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2007.00594.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2007.00594.x%26sid%3Dliteratum%253Aachs%26aulast%3DKothe%26aufirst%3DM.%26aulast%3DKohls%26aufirst%3DD.%26aulast%3DLow%26aufirst%3DS.%26aulast%3DColi%26aufirst%3DR.%26aulast%3DRennie%26aufirst%3DG.%2BR.%26aulast%3DFeru%26aufirst%3DF.%26aulast%3DKuhn%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DY.-H.%26atitle%3DSelectivity-determining%2520residues%2520in%2520Plk1%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2007%26volume%3D70%26spage%3D540%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span> </span><span class="NLM_article-title">Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2<i>)</i></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2647</span><span class="NLM_x">–</span> <span class="NLM_lpage">2654</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0611004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2647-2654&author=D.+R.+Andersonauthor=M.+J.+Meyersauthor=W.+F.+Vernierauthor=M.+W.+Mahoneyauthor=R.+G.+Kurumbailauthor=N.+Caspersauthor=G.+I.+Podaauthor=J.+F.+Schindlerauthor=D.+B.+Reitzauthor=R.+J.+Mourey&title=Pyrrolopyridine+inhibitors+of+mitogen-activated+protein+kinase-activated+protein+kinase+2+%28MK-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm0611004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611004%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DVernier%26aufirst%3DW.%2BF.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DReitz%26aufirst%3DD.%2BB.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26atitle%3DPyrrolopyridine%2520inhibitors%2520of%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2647%26epage%3D2654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyckman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newitt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding mode</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4120</span><span class="NLM_x">–</span> <span class="NLM_lpage">4126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=10.1016%2Fj.bmcl.2013.05.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=23746475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVCrsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4120-4126&author=S.+T.+Wrobleskiauthor=S.+Linauthor=T.+G.+Dharauthor=A.+J.+Dyckmanauthor=T.+Liauthor=S.+Pittauthor=R.+Zhangauthor=Y.+Fanauthor=A.+M.+Doweykoauthor=J.+S.+Tokarskiauthor=K.+F.+Kishauthor=S.+E.+Kieferauthor=J.+S.+Sackauthor=J.+A.+Newittauthor=M.+R.+Witmerauthor=M.+McKinnonauthor=J.+C.+Barrishauthor=J.+H.+Doddauthor=G.+L.+Schievenauthor=K.+Leftheris&title=The+identification+of+novel+p38%CE%B1+isoform+selective+kinase+inhibitors+having+an+unprecedented+p38%CE%B1+binding+mode"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding mode</span></div><div class="casAuthors">Wrobleski, Stephen T.; Lin, Shuqun; Murali Dhar, T. G.; Dyckman, Alaric J.; Li, Tianle; Pitt, Sidney; Zhang, Rosemary; Fan, Yi; Doweyko, Arthur M.; Tokarski, John S.; Kish, Kevin F.; Kiefer, Susan E.; Sack, John S.; Newitt, John A.; Witmer, Mark R.; McKinnon, Murray; Barrish, Joel C.; Dodd, John H.; Schieven, Gary L.; Leftheris, Katerina</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4120-4126</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel series of p38 MAP kinase inhibitors with high selectivity for the p38α isoform over the other family members including the highly homologous p38β isoform has been identified.  X-ray co-crystallog. studies have revealed an unprecedented kinase binding mode in p38α for representative analogs, I and II, in which a Leu108/Met109 peptide flip occurs within the p38α hinge region.  Based on these findings, a general strategy for the rational design of addnl. promising p38α isoform selective inhibitors by targeting this novel binding mode is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNxYBExGOM07Vg90H21EOLACvtfcHk0lhihQZUYIaXxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVCrsrg%253D&md5=a06080866fe221651762d46f4a474afb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.047%26sid%3Dliteratum%253Aachs%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DDhar%26aufirst%3DT.%2BG.%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DKish%26aufirst%3DK.%2BF.%26aulast%3DKiefer%26aufirst%3DS.%2BE.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DNewitt%26aufirst%3DJ.%2BA.%26aulast%3DWitmer%26aufirst%3DM.%2BR.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DThe%2520identification%2520of%2520novel%2520p38%25CE%25B1%2520isoform%2520selective%2520kinase%2520inhibitors%2520having%2520an%2520unprecedented%2520p38%25CE%25B1%2520binding%2520mode%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4120%26epage%3D4126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Medina, J. R.</span><span> </span><span class="NLM_article-title">Selective 3-phosphoinositide-dependent kinase 1 (PDK1) inhibitors: dissecting the function and pharmacology of PDK1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2726</span><span class="NLM_x">–</span> <span class="NLM_lpage">2737</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4000227" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2726-2737&author=J.+R.+Medina&title=Selective+3-phosphoinositide-dependent+kinase+1+%28PDK1%29+inhibitors%3A+dissecting+the+function+and+pharmacology+of+PDK1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm4000227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000227%26sid%3Dliteratum%253Aachs%26aulast%3DMedina%26aufirst%3DJ.%2BR.%26atitle%3DSelective%25203-phosphoinositide-dependent%2520kinase%25201%2520%2528PDK1%2529%2520inhibitors%253A%2520dissecting%2520the%2520function%2520and%2520pharmacology%2520of%2520PDK1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2726%26epage%3D2737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Ashford, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guichard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochhead, P. A.</span><span> </span><span class="NLM_article-title">A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3β to phosphorylate cyclin D1 at Thr286, not Thr288</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">457</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=457&publication_year=2014&pages=43-56&author=A.+L.+Ashfordauthor=D.+Oxleyauthor=J.+Kettleauthor=K.+Hudsonauthor=S.+Guichardauthor=S.+J.+Cookauthor=P.+A.+Lochhead&title=A+novel+DYRK1B+inhibitor+AZ191+demonstrates+that+DYRK1B+acts+independently+of+GSK3%CE%B2+to+phosphorylate+cyclin+D1+at+Thr286%2C+not+Thr288"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAshford%26aufirst%3DA.%2BL.%26aulast%3DOxley%26aufirst%3DD.%26aulast%3DKettle%26aufirst%3DJ.%26aulast%3DHudson%26aufirst%3DK.%26aulast%3DGuichard%26aufirst%3DS.%26aulast%3DCook%26aufirst%3DS.%2BJ.%26aulast%3DLochhead%26aufirst%3DP.%2BA.%26atitle%3DA%2520novel%2520DYRK1B%2520inhibitor%2520AZ191%2520demonstrates%2520that%2520DYRK1B%2520acts%2520independently%2520of%2520GSK3%25CE%25B2%2520to%2520phosphorylate%2520cyclin%2520D1%2520at%2520Thr286%252C%2520not%2520Thr288%26jtitle%3DBiochem.%2520J.%26date%3D2014%26volume%3D457%26spage%3D43%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11a','cit11b','cit11c','cit11d'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Lucia Fusani, David S. Palmer, Don O. Somers, <span class="NLM_string-name hlFld-ContribAuthor">Ian D. Wall</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring Ligand Stability in Protein Crystal Structures Using Binding Pose Metadynamics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (3)
                                     , 1528-1539. <a href="https://doi.org/10.1021/acs.jcim.9b00843" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00843</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00843%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DExploring%252BLigand%252BStability%252Bin%252BProtein%252BCrystal%252BStructures%252BUsing%252BBinding%252BPose%252BMetadynamics%26aulast%3DFusani%26aufirst%3DLucia%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D25092019%26date%3D22012020%26date%3D07012020%26volume%3D60%26issue%3D3%26spage%3D1528%26epage%3D1539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingqing  Zhou</span>, <span class="hlFld-ContribAuthor ">Athena F.  Phoa</span>, <span class="hlFld-ContribAuthor ">Ramzi H.  Abbassi</span>, <span class="hlFld-ContribAuthor ">Monira  Hoque</span>, <span class="hlFld-ContribAuthor ">Tristan A.  Reekie</span>, <span class="hlFld-ContribAuthor ">Josep S.  Font</span>, <span class="hlFld-ContribAuthor ">Renae M.  Ryan</span>, <span class="hlFld-ContribAuthor ">Brett W.  Stringer</span>, <span class="hlFld-ContribAuthor ">Bryan W.  Day</span>, <span class="hlFld-ContribAuthor ">Terrance G.  Johns</span>, <span class="hlFld-ContribAuthor ">Lenka  Munoz</span>, and <span class="hlFld-ContribAuthor ">Michael  Kassiou</span>  . </span><span class="cited-content_cbyCitation_article-title">Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (5)
                                     , 2052-2070. <a href="https://doi.org/10.1021/acs.jmedchem.6b01840" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01840</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01840%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BOptimization%252Band%252BPharmacological%252BEvaluation%252Bof%252BInhibitors%252BTargeting%252BDual-Specificity%252BTyrosine%252BPhosphorylation-Regulated%252BKinases%252B%252528DYRK%252529%252Band%252BCDC-like%252Bkinases%252B%252528CLK%252529%252Bin%252BGlioblastoma%26aulast%3DZhou%26aufirst%3DQingqing%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D16122016%26date%3D28022017%26date%3D09032017%26date%3D16022017%26volume%3D60%26issue%3D5%26spage%3D2052%26epage%3D2070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Areum  Park</span>, <span class="hlFld-ContribAuthor ">Jieon  Hwang</span>, <span class="hlFld-ContribAuthor ">Joo-Youn  Lee</span>, <span class="hlFld-ContribAuthor ">Eun Ji  Heo</span>, <span class="hlFld-ContribAuthor ">Yoon-Ju  Na</span>, <span class="hlFld-ContribAuthor ">Sein  Kang</span>, <span class="hlFld-ContribAuthor ">Kyu-Sung  Jeong</span>, <span class="hlFld-ContribAuthor ">Ki Young  Kim</span>, <span class="hlFld-ContribAuthor ">Sang Joon  Shin</span>, <span class="hlFld-ContribAuthor ">Hyuk  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel 1H-Pyrazolo[3,4-b]pyridine derivatives as DYRK 1A/1B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>47 </em>, 128226. <a href="https://doi.org/10.1016/j.bmcl.2021.128226" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128226</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128226%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252Bnovel%252B1H-Pyrazolo%25255B3%25252C4-b%25255Dpyridine%252Bderivatives%252Bas%252BDYRK%252B1A%25252F1B%252Binhibitors%26aulast%3DPark%26aufirst%3DAreum%26date%3D2021%26volume%3D47%26spage%3D128226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolaos  Kokkorakis</span>, <span class="hlFld-ContribAuthor ">Maria  Gaitanou</span>. </span><span class="cited-content_cbyCitation_article-title">Minibrain-related kinase/dual-specificity tyrosine-regulated kinase 1B implication in stem/cancer stem cells biology. </span><span class="cited-content_cbyCitation_journal-name">World Journal of Stem Cells</span><span> <strong>2020,</strong> <em>12 </em>
                                    (12)
                                     , 1553-1575. <a href="https://doi.org/10.4252/wjsc.v12.i12.1553" title="DOI URL">https://doi.org/10.4252/wjsc.v12.i12.1553</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4252/wjsc.v12.i12.1553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4252%2Fwjsc.v12.i12.1553%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Journal%2520of%2520Stem%2520Cells%26atitle%3DMinibrain-related%252Bkinase%25252Fdual-specificity%252Btyrosine-regulated%252Bkinase%252B1B%252Bimplication%252Bin%252Bstem%25252Fcancer%252Bstem%252Bcells%252Bbiology%26aulast%3DKokkorakis%26aufirst%3DNikolaos%26date%3D2020%26volume%3D12%26issue%3D12%26spage%3D1553%26epage%3D1575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacopo  Boni</span>, <span class="hlFld-ContribAuthor ">Carlota  Rubio-Perez</span>, <span class="hlFld-ContribAuthor ">Nuria  López-Bigas</span>, <span class="hlFld-ContribAuthor ">Cristina  Fillat</span>, <span class="hlFld-ContribAuthor ">Susana  de la Luna</span>. </span><span class="cited-content_cbyCitation_article-title">The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic Opportunities. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (8)
                                     , 2106. <a href="https://doi.org/10.3390/cancers12082106" title="DOI URL">https://doi.org/10.3390/cancers12082106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12082106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12082106%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BDYRK%252BFamily%252Bof%252BKinases%252Bin%252BCancer%25253A%252BMolecular%252BFunctions%252Band%252BTherapeutic%252BOpportunities%26aulast%3DBoni%26aufirst%3DJacopo%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D8%26spage%3D2106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lacey M.  Litchfield</span>, <span class="hlFld-ContribAuthor ">Karsten  Boehnke</span>, <span class="hlFld-ContribAuthor ">Manisha  Brahmachary</span>, <span class="hlFld-ContribAuthor ">Cecilia  Mur</span>, <span class="hlFld-ContribAuthor ">Chen  Bi</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Stephens</span>, <span class="hlFld-ContribAuthor ">J. Michael  Sauder</span>, <span class="hlFld-ContribAuthor ">Sonia M.  Gutiérrez</span>, <span class="hlFld-ContribAuthor ">Ann M.  McNulty</span>, <span class="hlFld-ContribAuthor ">Xiang S.  Ye</span>, <span class="hlFld-ContribAuthor ">Wenjuan  Wu</span>, <span class="hlFld-ContribAuthor ">María José  Lallena</span>, <span class="hlFld-ContribAuthor ">Xueqian  Gong</span>, <span class="hlFld-ContribAuthor ">Farhana F.  Merzoug</span>, <span class="hlFld-ContribAuthor ">Valerie M.  Jansen</span>, <span class="hlFld-ContribAuthor ">Sean G.  Buchanan</span>. </span><span class="cited-content_cbyCitation_article-title">Combined inhibition of PIM and CDK4/6 suppresses both mTOR signaling and Rb phosphorylation and potentiates PI3K inhibition in cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2020,</strong> <em>11 </em>
                                    (17)
                                     , 1478-1492. <a href="https://doi.org/10.18632/oncotarget.27539" title="DOI URL">https://doi.org/10.18632/oncotarget.27539</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.27539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.27539%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DCombined%252Binhibition%252Bof%252BPIM%252Band%252BCDK4%25252F6%252Bsuppresses%252Bboth%252BmTOR%252Bsignaling%252Band%252BRb%252Bphosphorylation%252Band%252Bpotentiates%252BPI3K%252Binhibition%252Bin%252Bcancer%252Bcells%26aulast%3DLitchfield%26aufirst%3DLacey%2BM.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D17%26spage%3D1478%26epage%3D1492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agnieszka  Szamborska-Gbur</span>, <span class="hlFld-ContribAuthor ">Ewelina  Rutkowska</span>, <span class="hlFld-ContribAuthor ">Agnieszka  Dreas</span>, <span class="hlFld-ContribAuthor ">Michael  Frid</span>, <span class="hlFld-ContribAuthor ">Maria  Vilenchik</span>, <span class="hlFld-ContribAuthor ">Mariusz  Milik</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Brzózka</span>, <span class="hlFld-ContribAuthor ">Marcin  Król</span>. </span><span class="cited-content_cbyCitation_article-title">How to design potent and selective DYRK1B inhibitors? Molecular modeling study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2019,</strong> <em>25 </em>
                                    (2)
                                     <a href="https://doi.org/10.1007/s00894-018-3921-3" title="DOI URL">https://doi.org/10.1007/s00894-018-3921-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-018-3921-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-018-3921-3%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DHow%252Bto%252Bdesign%252Bpotent%252Band%252Bselective%252BDYRK1B%252Binhibitors%25253F%252BMolecular%252Bmodeling%252Bstudy%26aulast%3DSzamborska-Gbur%26aufirst%3DAgnieszka%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Walter  Becker</span>. </span><span class="cited-content_cbyCitation_article-title">A wake‐up call to quiescent cancer cells – potential use of
              DYRK
              1B inhibitors in cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">The FEBS Journal</span><span> <strong>2018,</strong> <em>285 </em>
                                    (7)
                                     , 1203-1211. <a href="https://doi.org/10.1111/febs.14347" title="DOI URL">https://doi.org/10.1111/febs.14347</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/febs.14347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Ffebs.14347%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FEBS%2520Journal%26atitle%3DA%252Bwake%2525E2%252580%252590up%252Bcall%252Bto%252Bquiescent%252Bcancer%252Bcells%252B%2525E2%252580%252593%252Bpotential%252Buse%252Bof%252BDYRK%252B1B%252Binhibitors%252Bin%252Bcancer%252Btherapy%26aulast%3DBecker%26aufirst%3DWalter%26date%3D2018%26date%3D2017%26volume%3D285%26issue%3D7%26spage%3D1203%26epage%3D1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon J.  Shaw</span>, <span class="hlFld-ContribAuthor ">Dane A.  Goff</span>, <span class="hlFld-ContribAuthor ">Nan  Lin</span>, <span class="hlFld-ContribAuthor ">Rajinder  Singh</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">John  McLaughlin</span>, <span class="hlFld-ContribAuthor ">Kristen A.  Baltgalvis</span>, <span class="hlFld-ContribAuthor ">Donald G.  Payan</span>, <span class="hlFld-ContribAuthor ">Todd M.  Kinsella</span>. </span><span class="cited-content_cbyCitation_article-title">Developing DYRK inhibitors derived from the meridianins as a means of increasing levels of NFAT in the nucleus. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (11)
                                     , 2617-2621. <a href="https://doi.org/10.1016/j.bmcl.2017.03.037" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.03.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.03.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.03.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDeveloping%252BDYRK%252Binhibitors%252Bderived%252Bfrom%252Bthe%252Bmeridianins%252Bas%252Ba%252Bmeans%252Bof%252Bincreasing%252Blevels%252Bof%252BNFAT%252Bin%252Bthe%252Bnucleus%26aulast%3DShaw%26aufirst%3DSimon%2BJ.%26date%3D2017%26volume%3D27%26issue%3D11%26spage%3D2617%26epage%3D2621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabriella  Castoria</span>, <span class="hlFld-ContribAuthor ">Ferdinando  Auricchio</span>, <span class="hlFld-ContribAuthor ">Antimo  Migliaccio</span>. </span><span class="cited-content_cbyCitation_article-title">Extranuclear partners of androgen receptor: at the crossroads of proliferation, migration, and neuritogenesis. </span><span class="cited-content_cbyCitation_journal-name">The FASEB Journal</span><span> <strong>2017,</strong> <em>31 </em>
                                    (4)
                                     , 1289-1300. <a href="https://doi.org/10.1096/fj.201601047R" title="DOI URL">https://doi.org/10.1096/fj.201601047R</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1096/fj.201601047R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1096%2Ffj.201601047R%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FASEB%2520Journal%26atitle%3DExtranuclear%252Bpartners%252Bof%252Bandrogen%252Breceptor%25253A%252Bat%252Bthe%252Bcrossroads%252Bof%252Bproliferation%25252C%252Bmigration%25252C%252Band%252Bneuritogenesis%26aulast%3DCastoria%26aufirst%3DGabriella%26date%3D2017%26date%3D2016%26volume%3D31%26issue%3D4%26spage%3D1289%26epage%3D1300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0015.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. MEK inhibitor treatment of A375 melanoma cells results in significant upregulation of Dyrk1b, which is reduced by siRNA targeting Dyrk1b. Western blot is representative of at least two separate experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0016.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. siRNA-mediated knockdown of DYRK1b increases cell death in AZD6244-treated A375 cells. The percentage of dead cells plotted is the mean and SEM from four separate experiments. Statistically significant differences, compared with control (scrambled) siRNA, are indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0017.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Literature reported inhibitor of Dyrk1A and Dyrk1B, harmine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Key 6-Azaindole Intermediates and Inhibitors <b>19</b> and <b>31</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Br<sub>2</sub>, NaHCO<sub>3</sub>, MeOH, 0 °C, 3 h; (ii) PhSO<sub>2</sub>Cl, aq. NaOH, TBAHS, DCM, 0 °C, 1 h; (iii) PdCl2(dppf), Bis(pinacolato)diboron, KOAc, DME, 80 °C, 18 h; (iv) Pd(PPh<sub>3</sub>)<sub>4</sub>, 2,4-dichloropyrimidine, aq. Na<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C, 1 h; (v) aq. Na<sub>2</sub>CO<sub>3</sub>, dioxane, 120 °C, 0.5 h; (vi) NaH, MeI, 0 °C, 2 h; (vii) <i>p</i>TSA, 2-methoxy-4-(4-methylpiperazin-1-yl)aniline, NMP, 200 °C, 2 h; (viii) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, <i>trans</i>-stilbeneboronic acid, K<sub>2</sub>PO<sub>4</sub>·H<sub>2</sub>0, 130 °C, 0.5 h, then aq. Na<sub>2</sub>CO<sub>3</sub>, 140 °C, 40 min.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Diverse Dyrk1B Inhibitors <b>32</b> and <b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) AcCl, AlCl<sub>3</sub>, 25 °C, 18 h; (ii) PhSO<sub>2</sub>Cl, aq. NaOH, TBAHS, DCM, 0 °C, 40 min; (iii) 1,1-di-<i>tert</i>-butoxy-<i>N</i>,<i>N</i>-dimethylmethanamine, DMF, 80 °C, 1 h; (iv) acetimidamide·HCl, KO-<i>t</i>-Bu, DMA, 150 °C, 1 h; (v) PhCH<sub>2</sub>OH, DIAD, PPh<sub>3</sub>, THF, 25 °C, 18 h.</p></p></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0018.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structures of compound <b>23</b> bound in IGF1R (pink) and TTK (cyan) showing the change in orientation of the C-4 azaindole headgroup.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0019.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compounds used to infer the binding mode of azaindoles in Dyrk1B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0001.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structure of 10z-hymenialdisine <b>25</b> bound to CLK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0002.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Crystal structure of harmine <b>1</b> bound to Dyrk1A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0003.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structure of 10z-hymenialdisine <b>25</b> bound to CLK1 (orange) overlaid with compound <b>23</b> bound in IGF1R (pink). The atoms used in the measurement of the psi torsion are indicated in bold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/medium/jm-2015-00098b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0004.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Impact on survival of the combination of MEK inhibitor AZD6244 and Dyrk1B inhibition on A375 melanoma cell line. Dyrk1B inhibition is affected with inhibitors <b>19</b>, <b>31</b>, and <b>33</b>. A375 cells were treated with AZD6244 in the presence or absence of DYRK1b inhibitors <b>19</b>, <b>31</b>, or <b>33</b> at a concentration of 1.33 μM for 72 h. The viability of cells was evaluated using CellTraceTM calcein green AM and propidium iodide (PI) stains. The percentage of dead cells plotted is the mean and SEM from at least two separate experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/acs.jmedchem.5b00098/20150320/images/large/jm-2015-00098b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00098&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46710" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46710" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 22 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lee, K.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, E.</span><span> </span><span class="NLM_article-title">Mirk protein kinase is a mitogen-activated protein kinase substrate that mediates survival of colon cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">3631</span><span class="NLM_x">–</span> <span class="NLM_lpage">3637</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=3631-3637&author=K.-M.+Leeauthor=X.+Dengauthor=E.+Friedman&title=Mirk+protein+kinase+is+a+mitogen-activated+protein+kinase+substrate+that+mediates+survival+of+colon+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.-M.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DFriedman%26aufirst%3DE.%26atitle%3DMirk%2520protein%2520kinase%2520is%2520a%2520mitogen-activated%2520protein%2520kinase%2520substrate%2520that%2520mediates%2520survival%2520of%2520colon%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D3631%26epage%3D3637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mercer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewton, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazur, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, E.</span><span> </span><span class="NLM_article-title">Myrk/Dyrk1B mediates survival during the differentiation of C2C12 myoblasts</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">25788</span><span class="NLM_x">–</span> <span class="NLM_lpage">25801</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=25788-25801&author=S.+E.+Mercerauthor=D.+Z.+Ewtonauthor=X.+Dengauthor=S.+Limauthor=T.+R.+Mazurauthor=E.+Friedman&title=Myrk%2FDyrk1B+mediates+survival+during+the+differentiation+of+C2C12+myoblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMercer%26aufirst%3DS.%2BE.%26aulast%3DEwton%26aufirst%3DD.%2BZ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DLim%26aufirst%3DS.%26aulast%3DMazur%26aufirst%3DT.%2BR.%26aulast%3DFriedman%26aufirst%3DE.%26atitle%3DMyrk%252FDyrk1B%2520mediates%2520survival%2520during%2520the%2520differentiation%2520of%2520C2C12%2520myoblasts%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D25788%26epage%3D25801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Becker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joost, H. G.</span><span> </span><span class="NLM_article-title">Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity</span> <span class="citation_source-journal">Prog. Nucleic Acid Res. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=10.1016%2FS0079-6603%2808%2960503-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=9932450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=1%3ACAS%3A528%3ADyaK1MXnsFKnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1999&pages=1-17&author=W.+Beckerauthor=H.+G.+Joost&title=Structural+and+functional+characteristics+of+Dyrk%2C+a+novel+subfamily+of+protein+kinases+with+dual+specificity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity</span></div><div class="casAuthors">Becker, Walter; Joost, Hans-Georg</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Nucleic Acid Research and Molecular Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-17</span>CODEN:
                <span class="NLM_cas:coden">PNMBAF</span>;
        ISSN:<span class="NLM_cas:issn">0079-6603</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review with 40 refs.  Dyrk-related kinases represent a novel subfamily of protein kinases with unique structural and enzymic features.  Its members have been identified in distantly related organisms.  The yeast kinase, Yak1, has been characterized as a neg. regulator of growth.  Mnb from Drosophila is encoded by the minibrain gene, whose mutation results in specific defects in neurogenesis.  Its mammalian homolog, Dyrk1A, is activated by tyrosine phosphorylation in the activation loop between subdomains VII and VIII of the catalytic domain.  The human gene for Dyrk1A is located in the "Down syndrome crit. region" of chromosome 21 and is therefore a candidate gene for mental retardation in Down syndrome.  More recently, six addnl. mammalian Dyrk-related kinases have been identified (Dyrk1B, Dyrk1C, Dyrk2, Dyrk3, Dyrk4A, and Dyrk4B).  All members of the Dyrk family contain in the activation loop the tyrosines that are essential for the full activity of Dyrk1A.  Outside their catalytic domains, Dyrk kinases exhibit little sequence similarity except for a small segment immediately preceding the catalytic domain (DH-box, Dyrk homol. box).  An unusual enzymic property of Dyrk-related kinases is their ability to catalyze tyrosine-directed autophosphorylation as well as phosphorylation of serine/threonine residues in exogenous substrates.  The exact cellular function of the Dyrk kinases is yet unknown.  However, it appears reasonable to assume that they are involved in the regulation of cellular growth and/or development.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNSdgeZiMKybVg90H21EOLACvtfcHk0ljyx3remfaXmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnsFKnsQ%253D%253D&md5=1e7059810f856d0c38018ca285fc7e60</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0079-6603%2808%2960503-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6603%252808%252960503-6%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DJoost%26aufirst%3DH.%2BG.%26atitle%3DStructural%2520and%2520functional%2520characteristics%2520of%2520Dyrk%252C%2520a%2520novel%2520subfamily%2520of%2520protein%2520kinases%2520with%2520dual%2520specificity%26jtitle%3DProg.%2520Nucleic%2520Acid%2520Res.%2520Mol.%2520Biol.%26date%3D1999%26volume%3D62%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Friedman, E.</span><span> </span><span class="NLM_article-title">Mirk/Dyrk1B in cancer</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">274</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2007&pages=274-279&author=E.+Friedman&title=Mirk%2FDyrk1B+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFriedman%26aufirst%3DE.%26atitle%3DMirk%252FDyrk1B%2520in%2520cancer%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2007%26volume%3D102%26spage%3D274%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, E. A.</span><span> </span><span class="NLM_article-title">Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">2258</span><span class="NLM_x">–</span> <span class="NLM_lpage">2269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=10.1002%2Fijc.27917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=23114871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12rsbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2013&pages=2258-2269&author=J.+Huauthor=H.+Dengauthor=E.+A.+Friedman&title=Ovarian+cancer+cells%2C+not+normal+cells%2C+are+damaged+by+Mirk%2FDyrk1B+kinase+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition</span></div><div class="casAuthors">Hu, Jing; Deng, Holly; Friedman, Eileen A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2258-2269</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Prior studies had shown that the Mirk/dyrk1B gene is amplified/upregulated in about 75% of ovarian cancers, that protein levels of this kinase are elevated in quiescent G0 cells and that Mirk maintains tumor cells in quiescence by initiating rapid degrdn. of cyclin D isoforms and by phosphorylation of a member of the DREAM complex.  Depletion of Mirk/dyrk1B led to increased cyclin D levels, an elevated reactive oxygen species (ROS) content and loss of viability.  However, many normal cells in vivo are quiescent, and therefore, targeting a kinase found in quiescent cells might be problematic.  In our study, Mirk kinase activity was found to be higher in ovarian cancer cells than in normal cells.  Pharmacol. inhibition of Mirk/dyrk1B kinase increased cyclin D levels both in quiescent normal diploid cells and in quiescent CDKN2A-neg. ovarian cancer cells, but led to more active CDK4/cyclin D complexes in quiescent ovarian cancer cells, allowing them to escape G0/G1 quiescence, enter cycle with high ROS levels and undergo apoptosis.  The ROS scavenger N-acetyl cysteine reduced both the amt. of cleaved poly(ADP-ribose) polymerase (PARP) and the extent of cancer cell loss.  In contrast, normal cells were spared because of their expression of cyclin directed kinase (CDK) inhibitors that blocked unregulated cycling.  Quiescent early passage normal ovarian epithelial cells and two strains of quiescent normal diploid fibroblasts remained viable after the inhibition of Mirk/dyrk1B kinase, and the few cells that left G0/G1 quiescence were accumulated in G2+M.  Thus, inhibition of Mirk kinase targeted quiescent ovarian cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWFUPgfQBJiLVg90H21EOLACvtfcHk0lip2yXjtyHWlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12rsbfF&md5=e0cf1c67ac4a66f2e12055bb0df0df0b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fijc.27917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.27917%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DH.%26aulast%3DFriedman%26aufirst%3DE.%2BA.%26atitle%3DOvarian%2520cancer%2520cells%252C%2520not%2520normal%2520cells%252C%2520are%2520damaged%2520by%2520Mirk%252FDyrk1B%2520kinase%2520inhibition%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2013%26volume%3D132%26spage%3D2258%26epage%3D2269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornicek, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, Z.</span><span> </span><span class="NLM_article-title">The kinase Mirk is a potential therapeutic target in osteosarcoma</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">558</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=552-558&author=C.+Yangauthor=D.+Jiauthor=E.+J.+Weinsteinauthor=E.+Choyauthor=F.+J.+Hornicekauthor=K.+B.+Woodauthor=X.+Liuauthor=H.+Mankinauthor=Z.+Duan&title=The+kinase+Mirk+is+a+potential+therapeutic+target+in+osteosarcoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%26aulast%3DJi%26aufirst%3DD.%26aulast%3DWeinstein%26aufirst%3DE.%2BJ.%26aulast%3DChoy%26aufirst%3DE.%26aulast%3DHornicek%26aufirst%3DF.%2BJ.%26aulast%3DWood%26aufirst%3DK.%2BB.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMankin%26aufirst%3DH.%26aulast%3DDuan%26aufirst%3DZ.%26atitle%3DThe%2520kinase%2520Mirk%2520is%2520a%2520potential%2520therapeutic%2520target%2520in%2520osteosarcoma%26jtitle%3DCarcinogenesis%26date%3D2010%26volume%3D31%26spage%3D552%26epage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Keramati, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fathzadeh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Go, G.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faramarzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mane, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasaei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarajzadeh-Fard, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kidd, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babaee Bigi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malekzadeh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosseinian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babaei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lifton, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mani, A.</span><span> </span><span class="NLM_article-title">A form of the metabolic syndrome associated with mutations in DYRK1B</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">1909</span><span class="NLM_x">–</span> <span class="NLM_lpage">1919</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=10.1056%2FNEJMoa1301824" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=24827035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGksbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=1909-1919&author=A.+R.+Keramatiauthor=M.+Fathzadehauthor=G.-W.+Goauthor=R.+Singhauthor=M.+Choiauthor=S.+Faramarziauthor=S.+Maneauthor=M.+Kasaeiauthor=K.+Sarajzadeh-Fardauthor=J.+Hwaauthor=K.+K.+Kiddauthor=M.+A.+Babaee+Bigiauthor=R.+Malekzadehauthor=A.+Hosseinianauthor=M.+Babaeiauthor=R.+P.+Liftonauthor=A.+Mani&title=A+form+of+the+metabolic+syndrome+associated+with+mutations+in+DYRK1B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A form of the metabolic syndrome associated with mutations in DYRK1B</span></div><div class="casAuthors">Keramati, Ali R.; Fathzadeh, Mohsen; Go, Gwang-Woong; Singh, Rajvir; Choi, Murim; Faramarzi, Saeed; Mane, Shrikant; Kasaei, Mohammad; Sarajzadeh-Fard, Kazem; Hwa, John; Kidd, Kenneth K.; Bigi, Mohammad A. Babaee; Malekzadeh, Reza; Hosseinian, Adallat; Babaei, Masoud; Lifton, Richard P.; Mani, Arya</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1909-1919, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Genetic anal. has been successful in identifying causative mutations for individual cardiovascular risk factors.  Success has been more limited in mapping susceptibility genes for clusters of cardiovascular risk traits, such as those in the metabolic syndrome.  Methods: We identified three large families with coinheritance of early-onset coronary artery disease, central obesity, hypertension, and diabetes.  We used linkage anal. and whole-exome sequencing to identify the disease-causing gene.  Results: A founder mutation was identified in DYRK1B, substituting cysteine for arginine at position 102 in the highly conserved kinase-like domain.  The mutation precisely cosegregated with the clin. syndrome in all the affected family members and was absent in unaffected family members and unrelated controls.  Functional characterization of the disease gene revealed that nonmutant protein encoded by DYRK1B inhibits the SHH (sonic hedgehog) and Wnt signaling pathways and consequently enhances adipogenesis.  Furthermore, DYRK1B promoted the expression of the key gluconeogenic enzyme glucose-6-phosphatase.  The R102C allele showed gain-of-function activities by potentiating these effects.  A second mutation, substituting proline for histidine 90, was found to cosegregate with a similar clin. syndrome in an ethnically distinct family.  Conclusions: These findings indicate a role for DYRK1B in adipogenesis and glucose homeostasis and assoc. its altered function with an inherited form of the metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ4PIrgg04UbVg90H21EOLACvtfcHk0lip2yXjtyHWlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGksbnO&md5=a964b3a4c701294e46ddfcdf1de76b14</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1301824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1301824%26sid%3Dliteratum%253Aachs%26aulast%3DKeramati%26aufirst%3DA.%2BR.%26aulast%3DFathzadeh%26aufirst%3DM.%26aulast%3DGo%26aufirst%3DG.-W.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DChoi%26aufirst%3DM.%26aulast%3DFaramarzi%26aufirst%3DS.%26aulast%3DMane%26aufirst%3DS.%26aulast%3DKasaei%26aufirst%3DM.%26aulast%3DSarajzadeh-Fard%26aufirst%3DK.%26aulast%3DHwa%26aufirst%3DJ.%26aulast%3DKidd%26aufirst%3DK.%2BK.%26aulast%3DBabaee%2BBigi%26aufirst%3DM.%2BA.%26aulast%3DMalekzadeh%26aufirst%3DR.%26aulast%3DHosseinian%26aufirst%3DA.%26aulast%3DBabaei%26aufirst%3DM.%26aulast%3DLifton%26aufirst%3DR.%2BP.%26aulast%3DMani%26aufirst%3DA.%26atitle%3DA%2520form%2520of%2520the%2520metabolic%2520syndrome%2520associated%2520with%2520mutations%2520in%2520DYRK1B%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26spage%3D1909%26epage%3D1919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Loidreau, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubouilh-Benard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nourrisson, M.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duflos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loaëc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of <i>N</i>-aryl-7-methoxybenzo[<i>b</i>]furo[3,2-<i>d</i>]pyrimidin-4-amines and their <i>N</i>-arylbenzo[<i>b</i>]thieno[3,2-<i>d</i>]pyrimidin-4-amine analogues as dual inhibitors of CLK1 and DYRK1A kinases</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2013&pages=283-295&author=Y.+Loidreauauthor=P.+Marchandauthor=C.+Dubouilh-Benardauthor=M.-R.+Nourrissonauthor=M.+Duflosauthor=N.+Loa%C3%ABcauthor=L.+Meijerauthor=T.+Besson&title=Synthesis+and+biological+evaluation+of+N-aryl-7-methoxybenzo%5Bb%5Dfuro%5B3%2C2-d%5Dpyrimidin-4-amines+and+their+N-arylbenzo%5Bb%5Dthieno%5B3%2C2-d%5Dpyrimidin-4-amine+analogues+as+dual+inhibitors+of+CLK1+and+DYRK1A+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLoidreau%26aufirst%3DY.%26aulast%3DMarchand%26aufirst%3DP.%26aulast%3DDubouilh-Benard%26aufirst%3DC.%26aulast%3DNourrisson%26aufirst%3DM.-R.%26aulast%3DDuflos%26aufirst%3DM.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520N-aryl-7-methoxybenzo%255Bb%255Dfuro%255B3%252C2-d%255Dpyrimidin-4-amines%2520and%2520their%2520N-arylbenzo%255Bb%255Dthieno%255B3%252C2-d%255Dpyrimidin-4-amine%2520analogues%2520as%2520dual%2520inhibitors%2520of%2520CLK1%2520and%2520DYRK1A%2520kinases%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D59%26spage%3D283%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span> </span><span class="NLM_article-title">Discovery of potent small molecule inhibitors of DYRK1A by structure-based virtual screening and bioassay</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=168-171&author=D.+Wangauthor=F.+Wangauthor=Y.+Tanauthor=L.+Dongauthor=L.+Chenauthor=W.+Zhuauthor=H.+Wang&title=Discovery+of+potent+small+molecule+inhibitors+of+DYRK1A+by+structure-based+virtual+screening+and+bioassay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DTan%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520potent%2520small%2520molecule%2520inhibitors%2520of%2520DYRK1A%2520by%2520structure-based%2520virtual%2520screening%2520and%2520bioassay%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D168%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Altafaj, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierssen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baamonde, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oset, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalex, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillat, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estivill, X.</span><span> </span><span class="NLM_article-title">Neurodevelopmental delay, motor abnormalities and cognitive defects in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down’s syndrome</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1915</span><span class="NLM_x">–</span> <span class="NLM_lpage">1923</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=10.1093%2Fhmg%2F10.18.1915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=11555628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntlSgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2001&pages=1915-1923&author=X.+Altafajauthor=M.+Dierssenauthor=C.+Baamondeauthor=E.+Martiauthor=J.+Visaauthor=J.+Guimeraauthor=M.+Osetauthor=J.+Gonzalexauthor=J.+Florezauthor=C.+Fillatauthor=X.+Estivill&title=Neurodevelopmental+delay%2C+motor+abnormalities+and+cognitive+defects+in+transgenic+mice+overexpressing+Dyrk1A+%28minibrain%29%2C+a+murine+model+of+Down%E2%80%99s+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome</span></div><div class="casAuthors">Altafaj, Xavier; Dierssen, Mara; Baamonde, Carmela; Marti, Eulalia; Visa, Joana; Guimera, Jordi; Oset, Marta; Gonzalez, Juan Ramon; Florez, Jesus; Fillat, Cristina; Estivill, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1915-1923</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Down's syndrome (DS) is a major cause of mental retardation, hypotonia and delayed development.  Murine models of DS carrying large murine or human genomic fragments show motor alterations and memory deficits.  The specific genes responsible for these phenotypic alterations have not yet been defined.  DYRK1A, the human homolog of the Drosophila minibrain gene, maps to the DS crit. region of human chromosome 21 and is overexpressed in DS fetal brain.  DYRK1A encodes a serine-threonine kinase, probably involved in neuroblast proliferation.  Mutant Drosophila minibrain flies have a redn. in both optic lobes and central brain, showing learning deficits and hypoactivity.  We have generated transgenic mice (TgDyrk1A) overexpressing the full-length cDNA of Dyrk1A.  TgDyrk1A mice exhibit delayed craniocaudal maturation with functional consequences in neuromotor development.  TgDyrk1A mice also show altered motor skill acquisition and hyperactivity, which is maintained to adulthood.  In the Morris water maze, TgDyrk1A mice show a significant impairment in spatial learning and cognitive flexibility, indicative of hippocampal and prefrontal cortex dysfunction.  In the more complex repeated reversal learning paradigm, this defect turned out to be specifically related to ref. memory, whereas working memory was almost unimpaired.  These alterations are comparable with those found in the partial trisomy chromosome 16 murine models of DS and suggest a causative role of DYRK1A in mental retardation and in motor anomalies of DS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwXDiQutGJ07Vg90H21EOLACvtfcHk0ljAvuN5w6weyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntlSgsb0%253D&md5=f31c3a38ca72e9d5709a489f34732b6a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F10.18.1915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F10.18.1915%26sid%3Dliteratum%253Aachs%26aulast%3DAltafaj%26aufirst%3DX.%26aulast%3DDierssen%26aufirst%3DM.%26aulast%3DBaamonde%26aufirst%3DC.%26aulast%3DMarti%26aufirst%3DE.%26aulast%3DVisa%26aufirst%3DJ.%26aulast%3DGuimera%26aufirst%3DJ.%26aulast%3DOset%26aufirst%3DM.%26aulast%3DGonzalex%26aufirst%3DJ.%26aulast%3DFlorez%26aufirst%3DJ.%26aulast%3DFillat%26aufirst%3DC.%26aulast%3DEstivill%26aufirst%3DX.%26atitle%3DNeurodevelopmental%2520delay%252C%2520motor%2520abnormalities%2520and%2520cognitive%2520defects%2520in%2520transgenic%2520mice%2520overexpressing%2520Dyrk1A%2520%2528minibrain%2529%252C%2520a%2520murine%2520model%2520of%2520Down%25E2%2580%2599s%2520syndrome%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2001%26volume%3D10%26spage%3D1915%26epage%3D1923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Metro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minotti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crino, L.</span><span> </span><span class="NLM_article-title">Selumetinib: a promising pharmacologic approach for KRAS-mutant advanced non-small-cell lung cancer</span> <span class="citation_source-journal">Future Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=10.2217%2Ffon.12.198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=23414467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1Chsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=167-177&author=G.+Metroauthor=R.+Chiariauthor=A.+Baldiauthor=V.+De+Angelisauthor=V.+Minottiauthor=L.+Crino&title=Selumetinib%3A+a+promising+pharmacologic+approach+for+KRAS-mutant+advanced+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Selumetinib: a promising pharmacologic approach for KRAS-mutant advanced non-small-cell lung cancer</span></div><div class="casAuthors">Metro, Giulio; Chiari, Rita; Baldi, Alice; De Angelis, Verena; Minotti, Vincenzo; Crino, Lucio</div><div class="citationInfo"><span class="NLM_cas:title">Future Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-177</span>CODEN:
                <span class="NLM_cas:coden">FOUNBN</span>;
        ISSN:<span class="NLM_cas:issn">1479-6694</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Selumetinib is a potent and selective inhibitor of MEK1 and 2 that is currently being clin. developed for the treatment of several human malignancies.  Initially administered as free-base suspension, a more convenient Hyd-sulfate capsule formulation has recently been developed.  Phase I studies revealed that acneiform dermatitis was the dose-limiting toxicity of both the free-base and capsule formulation given two-times a day at the max. tolerated doses of 100 and 75 mg, resp., with the capsule formulation resulting into a significantly higher drug bioavailability.  Importantly, as a MEK inhibitor, selumetinib could be particularly effective in tumors with a hyperactivated Ras/Raf/MEK/ERK pathway, which might be the case of KRAS-mutant non-small-cell lung cancers (NSCLCs).  Accordingly, a recent randomized Phase II study evaluating docetaxel plus selumetinib or placebo in KRAS-mutant pretreated advanced NSCLC patients has demonstrated a significant improvement in terms of response rate, progression-free survival and patient-reported outcomes in favor of the combination arm.  These pos. results support further clin. evaluation of selumetinib in NSCLC, and confirmatory ongoing and future trials will assess its role according to KRAS-mutation status and in combination regimens with other targeted agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxRYBFujBPTbVg90H21EOLACvtfcHk0ljAvuN5w6weyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1Chsrw%253D&md5=c383f88192524739b6d57f99fa1bc173</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2217%2Ffon.12.198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffon.12.198%26sid%3Dliteratum%253Aachs%26aulast%3DMetro%26aufirst%3DG.%26aulast%3DChiari%26aufirst%3DR.%26aulast%3DBaldi%26aufirst%3DA.%26aulast%3DDe%2BAngelis%26aufirst%3DV.%26aulast%3DMinotti%26aufirst%3DV.%26aulast%3DCrino%26aufirst%3DL.%26atitle%3DSelumetinib%253A%2520a%2520promising%2520pharmacologic%2520approach%2520for%2520KRAS-mutant%2520advanced%2520non-small-cell%2520lung%2520cancer%26jtitle%3DFuture%2520Oncol.%26date%3D2013%26volume%3D9%26spage%3D167%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Cohen, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aamdal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyakas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavallin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Learoyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurzrock, R.</span><span> </span><span class="NLM_article-title">A phase I dose-finding, safety and tolerability study of AZD8330 in patients with advanced malignancies</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1521</span><span class="NLM_x">–</span> <span class="NLM_lpage">1529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=1521-1529&author=R.+B.+Cohenauthor=S.+Aamdalauthor=M.+Nyakasauthor=M.+Cavallinauthor=D.+Greenauthor=M.+Learoydauthor=I.+Smithauthor=R.+Kurzrock&title=A+phase+I+dose-finding%2C+safety+and+tolerability+study+of+AZD8330+in+patients+with+advanced+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DR.%2BB.%26aulast%3DAamdal%26aufirst%3DS.%26aulast%3DNyakas%26aufirst%3DM.%26aulast%3DCavallin%26aufirst%3DM.%26aulast%3DGreen%26aufirst%3DD.%26aulast%3DLearoyd%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DI.%26aulast%3DKurzrock%26aufirst%3DR.%26atitle%3DA%2520phase%2520I%2520dose-finding%252C%2520safety%2520and%2520tolerability%2520study%2520of%2520AZD8330%2520in%2520patients%2520with%2520advanced%2520malignancies%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2013%26volume%3D49%26spage%3D1521%26epage%3D1529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Anderson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominique, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luk, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polonskaia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Railkar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenchik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wovkulich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span> </span><span class="NLM_article-title">Pyrido[2,3-d]pyrimidines: discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6610</span><span class="NLM_x">–</span> <span class="NLM_lpage">6615</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6610-6615&author=K.+Andersonauthor=Y.+Chenauthor=Z.+Chenauthor=R.+Dominiqueauthor=K.+Glennauthor=Y.+Heauthor=C.+Jansonauthor=K.-C.+Lukauthor=C.+Lukacsauthor=A.+Polonskaiaauthor=Q.+Qiaoauthor=A.+Railkarauthor=P.+Rossmanauthor=H.+Sunauthor=Q.+Xiangauthor=M.+Vilenchikauthor=P.+Wovkulichauthor=X.+Zhang&title=Pyrido%5B2%2C3-d%5Dpyrimidines%3A+discovery+and+preliminary+SAR+of+a+novel+series+of+DYRK1B+and+DYRK1A+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDominique%26aufirst%3DR.%26aulast%3DGlenn%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DJanson%26aufirst%3DC.%26aulast%3DLuk%26aufirst%3DK.-C.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DPolonskaia%26aufirst%3DA.%26aulast%3DQiao%26aufirst%3DQ.%26aulast%3DRailkar%26aufirst%3DA.%26aulast%3DRossman%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DXiang%26aufirst%3DQ.%26aulast%3DVilenchik%26aufirst%3DM.%26aulast%3DWovkulich%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DPyrido%255B2%252C3-d%255Dpyrimidines%253A%2520discovery%2520and%2520preliminary%2520SAR%2520of%2520a%2520novel%2520series%2520of%2520DYRK1B%2520and%2520DYRK1A%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6610%26epage%3D6615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Coombs, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanega, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auld, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerritz, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenen, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aube, J.</span><span> </span><span class="NLM_article-title">Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3654</span><span class="NLM_x">–</span> <span class="NLM_lpage">3661</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3654-3661&author=T.+C.+Coombsauthor=C.+Tanegaauthor=M.+Shenauthor=J.+L.+Wangauthor=D.+S.+Auldauthor=S.+W.+Gerritzauthor=F.+J.+Schoenenauthor=C.+J.+Thomasauthor=J.+Aube&title=Small-molecule+pyrimidine+inhibitors+of+the+cdc2-like+%28Clk%29+and+dual+specificity+tyrosine+phosphorylation-regulated+%28Dyrk%29+kinases%3A+development+of+chemical+probe+ML315"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoombs%26aufirst%3DT.%2BC.%26aulast%3DTanega%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%2BL.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DGerritz%26aufirst%3DS.%2BW.%26aulast%3DSchoenen%26aufirst%3DF.%2BJ.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DAube%26aufirst%3DJ.%26atitle%3DSmall-molecule%2520pyrimidine%2520inhibitors%2520of%2520the%2520cdc2-like%2520%2528Clk%2529%2520and%2520dual%2520specificity%2520tyrosine%2520phosphorylation-regulated%2520%2528Dyrk%2529%2520kinases%253A%2520development%2520of%2520chemical%2520probe%2520ML315%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3654%26epage%3D3661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rosse, G.</span><span> </span><span class="NLM_article-title">Tricyclic pyrimidines as inhibitors of DYRK1A/DYRK1B as potential treatment for Down’s syndrome or Alzheimer’s disease</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">502</span><span class="NLM_x">–</span> <span class="NLM_lpage">503</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml400137s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=502-503&author=G.+Rosse&title=Tricyclic+pyrimidines+as+inhibitors+of+DYRK1A%2FDYRK1B+as+potential+treatment+for+Down%E2%80%99s+syndrome+or+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1021%2Fml400137s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400137s%26sid%3Dliteratum%253Aachs%26aulast%3DRosse%26aufirst%3DG.%26atitle%3DTricyclic%2520pyrimidines%2520as%2520inhibitors%2520of%2520DYRK1A%252FDYRK1B%2520as%2520potential%2520treatment%2520for%2520Down%25E2%2580%2599s%2520syndrome%2520or%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D502%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Schmitt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kail, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Empting, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of a library of lead-like 2,4-bisheterocyclic substituted thiophenes as selective Dyrk/Clk inhibitors</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e87851</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e87851&author=C.+Schmittauthor=D.+Kailauthor=M.+Marianoauthor=M.+Emptingauthor=N.+Weberauthor=T.+Paulauthor=R.+W.+Hartmannauthor=M.+Engel&title=Design+and+synthesis+of+a+library+of+lead-like+2%2C4-bisheterocyclic+substituted+thiophenes+as+selective+Dyrk%2FClk+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DC.%26aulast%3DKail%26aufirst%3DD.%26aulast%3DMariano%26aufirst%3DM.%26aulast%3DEmpting%26aufirst%3DM.%26aulast%3DWeber%26aufirst%3DN.%26aulast%3DPaul%26aufirst%3DT.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DEngel%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520library%2520of%2520lead-like%25202%252C4-bisheterocyclic%2520substituted%2520thiophenes%2520as%2520selective%2520Dyrk%252FClk%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De87851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Göckler, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jofre, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soppa, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejedor, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, W.</span><span> </span><span class="NLM_article-title">Harmine specifically inhibits protein kinase Dyrk1A and interferes with neurite formation</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">6324</span><span class="NLM_x">–</span> <span class="NLM_lpage">6337</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=6324-6337&author=N.+G%C3%B6cklerauthor=G.+Jofreauthor=C.+Papadopoulosauthor=U.+Soppaauthor=F.+J.+Tejedorauthor=W.+Becker&title=Harmine+specifically+inhibits+protein+kinase+Dyrk1A+and+interferes+with+neurite+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6ckler%26aufirst%3DN.%26aulast%3DJofre%26aufirst%3DG.%26aulast%3DPapadopoulos%26aufirst%3DC.%26aulast%3DSoppa%26aufirst%3DU.%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DHarmine%2520specifically%2520inhibits%2520protein%2520kinase%2520Dyrk1A%2520and%2520interferes%2520with%2520neurite%2520formation%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D6324%26epage%3D6337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shpiro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastie, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevernic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The selectivity of protein kinase inhibitors: a further update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&author=J.+Bainauthor=L.+Palterauthor=M.+Elliottauthor=N.+Shpiroauthor=C.+J.+Hastieauthor=H.+McLauchlanauthor=I.+Klevernicauthor=J.+S.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+selectivity+of+protein+kinase+inhibitors%3A+a+further+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0liT-NcWkEEjQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPalter%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%253A%2520a%2520further%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26spage%3D297%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesuma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, R. Z.</span><span> </span><span class="NLM_article-title">Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=10.1016%2Fj.bbrc.2004.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=15047157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVKmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2004&pages=128-132&author=Y.+Songauthor=D.+Kesumaauthor=J.+Wangauthor=Y.+Dengauthor=J.+Duanauthor=J.+H.+Wangauthor=R.+Z.+Qi&title=Specific+inhibition+of+cyclin-dependent+kinases+and+cell+proliferation+by+harmine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine</span></div><div class="casAuthors">Song, Yongcheng; Kesuma, Djohan; Wang, Jian; Deng, Yu; Duan, Jinao; Wang, Jerry H.; Qi, Robert Z.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-132</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">As key regulators of the cell proliferation cycle, cyclin-dependent kinases (CDKs) are attractive targets for the development of anti-tumor drugs.  In the present study, harmine was identified from a collection of herbal compds. to be a specific inhibitor of Cdk1/cyclin B, Cdk2/cyclin A, and Cdk5/p25 with IC50 values at low micromoles.  It displayed little effect on other serine/threonine and tyrosine kinases tested.  The CDK inhibition by harmine is competitive with ATP-Mg2+, suggesting that it binds to the ATP-Mg2+-binding pocket of CDKs.  In cytotoxicity assays, harmine exhibited a strong inhibitory effect on the growth and proliferation of carcinoma cells whereas it had no significant effect on quiescent fibroblasts.  Further, harmine was found to block DNA replication in the carcinoma cells.  Taken together, harmine is a selective inhibitor of CDKs and cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9drfO7NpUHrVg90H21EOLACvtfcHk0liT-NcWkEEjQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVKmt74%253D&md5=1a88a183ab790612a3e4c3d7c147eca6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2004.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2004.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DKesuma%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DQi%26aufirst%3DR.%2BZ.%26atitle%3DSpecific%2520inhibition%2520of%2520cyclin-dependent%2520kinases%2520and%2520cell%2520proliferation%2520by%2520harmine%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2004%26volume%3D317%26spage%3D128%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Waki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damoiseaux, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilpitz, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontonoz, P.</span><span> </span><span class="NLM_article-title">The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARgamma expression</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=10.1016%2Fj.cmet.2007.03.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=17488638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt1Wqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=357-370&author=H.+Wakiauthor=K.+W.+Parkauthor=N.+Mitroauthor=L.+Peiauthor=R.+Damoiseauxauthor=D.+C.+Wilpitzauthor=K.+Reueauthor=E.+Saezauthor=P.+Tontonoz&title=The+small+molecule+harmine+is+an+antidiabetic+cell-type-specific+regulator+of+PPARgamma+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARγ expression</span></div><div class="casAuthors">Waki, Hironori; Park, Kye Won; Mitro, Nico; Pei, Liming; Damoiseaux, Robert; Wilpitz, Damien C.; Reue, Karen; Saez, Enrique; Tontonoz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">357-370</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">PPARγ is the master regulator of adipogenesis and the mol. target of the thiazolidinedione antidiabetic drugs.  By screening for compds. that promote adipogenesis, we identified a small mol. that targets the PPARγ pathway by a distinct mechanism.  This mol., harmine, is not a ligand for the receptor; rather, it acts as a cell-type-specific regulator of PPARγ expression.  Administration of harmine to diabetic mice mimics the effects of PPARγ ligands on adipocyte gene expression and insulin sensitivity.  Unlike thiazolidinediones, however, harmine does not cause significant wt. gain or hepatic lipid accumulation.  Mol. studies indicate that harmine controls PPARγ expression through inhibition of the Wnt signaling pathway.  This work validates phenotypic screening of adipocytes as a promising strategy for the identification of bioactive small mols. and suggests that regulators of PPARγ expression may represent a complementary approach to PPARγ ligands in the treatment of insulin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Im5tRGS5LbVg90H21EOLACvtfcHk0liT-NcWkEEjQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt1Wqu7s%253D&md5=a2b9ff7b3eb65a8eef51d848d185b386</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2007.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2007.03.010%26sid%3Dliteratum%253Aachs%26aulast%3DWaki%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DK.%2BW.%26aulast%3DMitro%26aufirst%3DN.%26aulast%3DPei%26aufirst%3DL.%26aulast%3DDamoiseaux%26aufirst%3DR.%26aulast%3DWilpitz%26aufirst%3DD.%2BC.%26aulast%3DReue%26aufirst%3DK.%26aulast%3DSaez%26aufirst%3DE.%26aulast%3DTontonoz%26aufirst%3DP.%26atitle%3DThe%2520small%2520molecule%2520harmine%2520is%2520an%2520antidiabetic%2520cell-type-specific%2520regulator%2520of%2520PPARgamma%2520expression%26jtitle%3DCell%2520Metab.%26date%3D2007%26volume%3D5%26spage%3D357%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sablin, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsay, R. R.</span><span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase A by beta-carboline derivatives</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">337</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=1997&pages=137-142&author=H.+Kimauthor=S.+O.+Sablinauthor=R.+R.+Ramsay&title=Inhibition+of+monoamine+oxidase+A+by+beta-carboline+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DSablin%26aufirst%3DS.%2BO.%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520A%2520by%2520beta-carboline%2520derivatives%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1997%26volume%3D337%26spage%3D137%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ducray, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissink, J. W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, K.</span><span> </span><span class="NLM_article-title">Discovery of novel imidazo[1,2-<i>a</i>]pyridines as inhibitors of the insulin-like growth factor-1 receptor tyrosine kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4698</span><span class="NLM_x">–</span> <span class="NLM_lpage">4701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4698-4701&author=R.+Ducrayauthor=I.+Simpsonauthor=F.+H.+Jungauthor=J.+W.+M.+Nissinkauthor=P.+W.+Kennyauthor=M.+Fitzekauthor=G.+E.+Walkerauthor=L.+T.+Wardauthor=K.+Hudson&title=Discovery+of+novel+imidazo%5B1%2C2-a%5Dpyridines+as+inhibitors+of+the+insulin-like+growth+factor-1+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDucray%26aufirst%3DR.%26aulast%3DSimpson%26aufirst%3DI.%26aulast%3DJung%26aufirst%3DF.%2BH.%26aulast%3DNissink%26aufirst%3DJ.%2BW.%2BM.%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DFitzek%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DG.%2BE.%26aulast%3DWard%26aufirst%3DL.%2BT.%26aulast%3DHudson%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520novel%2520imidazo%255B1%252C2-a%255Dpyridines%2520as%2520inhibitors%2520of%2520the%2520insulin-like%2520growth%2520factor-1%2520receptor%2520tyrosine%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4698%26epage%3D4701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Kothe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohls, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennie, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feru, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.-H.</span><span> </span><span class="NLM_article-title">Selectivity-determining residues in Plk1</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=10.1111%2Fj.1747-0285.2007.00594.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=18005335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGhsbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=540-546&author=M.+Kotheauthor=D.+Kohlsauthor=S.+Lowauthor=R.+Coliauthor=G.+R.+Rennieauthor=F.+Feruauthor=C.+Kuhnauthor=Y.-H.+Ding&title=Selectivity-determining+residues+in+Plk1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity-determining residues in Plk1</span></div><div class="casAuthors">Kothe, Michael; Kohls, Darcy; Low, Simon; Coli, Rocco; Rennie, Glen R.; Feru, Frederic; Kuhn, Cyrille; Ding, Yuan-Hua</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">540-546</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Polo-like kinase 1 is an important regulator of cell cycle progression whose over-expression is often assocd. with oncogenesis.  Polo-like kinase 1 hence represents an attractive target for cancer intervention.  BI 2536 (Boehringer Ingelheim, Ingelheim, Germany), a Polo-like kinase 1 inhibitor currently in clin. trials, exhibits nanomolar potency against Polo-like kinase isoforms and high selectivity against other kinases.  The authors have previously published the crystal structures of the Polo-like kinase 1 domain in complex with AMPPNP and an Aurora A inhibitor.  In this work, the authors present the cocrystal structure of Polo-like kinase 1 with BI 2536.  The structure, in combination with selectivity data for BI 2536 and related compds., illustrates important features for potency and selectivity.  In particular, the authors show that the methoxy group of BI 2536 is an important specificity determinant against non-Polo-like kinases by taking advantage of a small pocket generated by Leu 132 in the hinge region of Polo-like kinase 1.  The work presented here provides a framework for structure-based drug design of Polo-like kinase 1-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjA3mwWD7K0bVg90H21EOLACvtfcHk0lh8gaqnLGO7kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGhsbrJ&md5=0f976bb98fe7d0413e8d2314abc68e2b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2007.00594.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2007.00594.x%26sid%3Dliteratum%253Aachs%26aulast%3DKothe%26aufirst%3DM.%26aulast%3DKohls%26aufirst%3DD.%26aulast%3DLow%26aufirst%3DS.%26aulast%3DColi%26aufirst%3DR.%26aulast%3DRennie%26aufirst%3DG.%2BR.%26aulast%3DFeru%26aufirst%3DF.%26aulast%3DKuhn%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DY.-H.%26atitle%3DSelectivity-determining%2520residues%2520in%2520Plk1%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2007%26volume%3D70%26spage%3D540%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span> </span><span class="NLM_article-title">Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2<i>)</i></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2647</span><span class="NLM_x">–</span> <span class="NLM_lpage">2654</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0611004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2647-2654&author=D.+R.+Andersonauthor=M.+J.+Meyersauthor=W.+F.+Vernierauthor=M.+W.+Mahoneyauthor=R.+G.+Kurumbailauthor=N.+Caspersauthor=G.+I.+Podaauthor=J.+F.+Schindlerauthor=D.+B.+Reitzauthor=R.+J.+Mourey&title=Pyrrolopyridine+inhibitors+of+mitogen-activated+protein+kinase-activated+protein+kinase+2+%28MK-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm0611004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611004%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DVernier%26aufirst%3DW.%2BF.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DReitz%26aufirst%3DD.%2BB.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26atitle%3DPyrrolopyridine%2520inhibitors%2520of%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2647%26epage%3D2654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyckman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newitt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding mode</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4120</span><span class="NLM_x">–</span> <span class="NLM_lpage">4126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=10.1016%2Fj.bmcl.2013.05.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=23746475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVCrsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4120-4126&author=S.+T.+Wrobleskiauthor=S.+Linauthor=T.+G.+Dharauthor=A.+J.+Dyckmanauthor=T.+Liauthor=S.+Pittauthor=R.+Zhangauthor=Y.+Fanauthor=A.+M.+Doweykoauthor=J.+S.+Tokarskiauthor=K.+F.+Kishauthor=S.+E.+Kieferauthor=J.+S.+Sackauthor=J.+A.+Newittauthor=M.+R.+Witmerauthor=M.+McKinnonauthor=J.+C.+Barrishauthor=J.+H.+Doddauthor=G.+L.+Schievenauthor=K.+Leftheris&title=The+identification+of+novel+p38%CE%B1+isoform+selective+kinase+inhibitors+having+an+unprecedented+p38%CE%B1+binding+mode"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding mode</span></div><div class="casAuthors">Wrobleski, Stephen T.; Lin, Shuqun; Murali Dhar, T. G.; Dyckman, Alaric J.; Li, Tianle; Pitt, Sidney; Zhang, Rosemary; Fan, Yi; Doweyko, Arthur M.; Tokarski, John S.; Kish, Kevin F.; Kiefer, Susan E.; Sack, John S.; Newitt, John A.; Witmer, Mark R.; McKinnon, Murray; Barrish, Joel C.; Dodd, John H.; Schieven, Gary L.; Leftheris, Katerina</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4120-4126</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel series of p38 MAP kinase inhibitors with high selectivity for the p38α isoform over the other family members including the highly homologous p38β isoform has been identified.  X-ray co-crystallog. studies have revealed an unprecedented kinase binding mode in p38α for representative analogs, I and II, in which a Leu108/Met109 peptide flip occurs within the p38α hinge region.  Based on these findings, a general strategy for the rational design of addnl. promising p38α isoform selective inhibitors by targeting this novel binding mode is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNxYBExGOM07Vg90H21EOLACvtfcHk0lj-4QzT1BqbWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVCrsrg%253D&md5=a06080866fe221651762d46f4a474afb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.047%26sid%3Dliteratum%253Aachs%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DDhar%26aufirst%3DT.%2BG.%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DKish%26aufirst%3DK.%2BF.%26aulast%3DKiefer%26aufirst%3DS.%2BE.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DNewitt%26aufirst%3DJ.%2BA.%26aulast%3DWitmer%26aufirst%3DM.%2BR.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DThe%2520identification%2520of%2520novel%2520p38%25CE%25B1%2520isoform%2520selective%2520kinase%2520inhibitors%2520having%2520an%2520unprecedented%2520p38%25CE%25B1%2520binding%2520mode%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4120%26epage%3D4126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Medina, J. R.</span><span> </span><span class="NLM_article-title">Selective 3-phosphoinositide-dependent kinase 1 (PDK1) inhibitors: dissecting the function and pharmacology of PDK1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2726</span><span class="NLM_x">–</span> <span class="NLM_lpage">2737</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4000227" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2726-2737&author=J.+R.+Medina&title=Selective+3-phosphoinositide-dependent+kinase+1+%28PDK1%29+inhibitors%3A+dissecting+the+function+and+pharmacology+of+PDK1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm4000227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000227%26sid%3Dliteratum%253Aachs%26aulast%3DMedina%26aufirst%3DJ.%2BR.%26atitle%3DSelective%25203-phosphoinositide-dependent%2520kinase%25201%2520%2528PDK1%2529%2520inhibitors%253A%2520dissecting%2520the%2520function%2520and%2520pharmacology%2520of%2520PDK1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2726%26epage%3D2737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Ashford, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guichard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochhead, P. A.</span><span> </span><span class="NLM_article-title">A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3β to phosphorylate cyclin D1 at Thr286, not Thr288</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">457</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=457&publication_year=2014&pages=43-56&author=A.+L.+Ashfordauthor=D.+Oxleyauthor=J.+Kettleauthor=K.+Hudsonauthor=S.+Guichardauthor=S.+J.+Cookauthor=P.+A.+Lochhead&title=A+novel+DYRK1B+inhibitor+AZ191+demonstrates+that+DYRK1B+acts+independently+of+GSK3%CE%B2+to+phosphorylate+cyclin+D1+at+Thr286%2C+not+Thr288"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAshford%26aufirst%3DA.%2BL.%26aulast%3DOxley%26aufirst%3DD.%26aulast%3DKettle%26aufirst%3DJ.%26aulast%3DHudson%26aufirst%3DK.%26aulast%3DGuichard%26aufirst%3DS.%26aulast%3DCook%26aufirst%3DS.%2BJ.%26aulast%3DLochhead%26aufirst%3DP.%2BA.%26atitle%3DA%2520novel%2520DYRK1B%2520inhibitor%2520AZ191%2520demonstrates%2520that%2520DYRK1B%2520acts%2520independently%2520of%2520GSK3%25CE%25B2%2520to%2520phosphorylate%2520cyclin%2520D1%2520at%2520Thr286%252C%2520not%2520Thr288%26jtitle%3DBiochem.%2520J.%26date%3D2014%26volume%3D457%26spage%3D43%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4D2S" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4D2S','PDB','4D2S'); return false;">PDB: 4D2S</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4D2R" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4D2R','PDB','4D2R'); return false;">PDB: 4D2R</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z57" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Z57','PDB','1Z57'); return false;">PDB: 1Z57</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P3G" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2P3G','PDB','2P3G'); return false;">PDB: 2P3G</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ANR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ANR','PDB','3ANR'); return false;">PDB: 3ANR</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i31"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00098">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_22677"></div></div></div></div></div><hr /></hr><p class="last">Protocols for the enzyme and cell assays, synthetic methods for the remaining examples, crystallographic information, and kinase panel selectivity data for compounds in Table <a class="ref showTableEvent internalNav" href="#tbl5">5</a>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00098/suppl_file/jm5b00098_si_001.pdf">jm5b00098_si_001.pdf (433.45 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00098&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00098%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-6%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00098" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679978924cee3d60","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
